William did not come in to talk about his heart.

He came for a men’s-health visit — erectile dysfunction, some fatigue, nothing dramatic. He was 55, stressed, tired, and quietly worried that he no longer felt like himself.

His primary care doctor had recently told him his cholesterol looked normal and his risk was low. He believed it. His numbers looked fine: LDL-C 108 mg/dL, HDL-C 52 mg/dL, triglycerides 118 mg/dL, total cholesterol 182 mg/dL.

But in midlife men, erectile dysfunction is often an early vascular clue. Men with ED carry higher future rates of cardiovascular disease, stroke, and death than men without it (2019 meta-analysis; Circulation: Outcomes analysis). None of that made him a cardiac patient. It did mean the routine panel had left the real question open.

So we looked further, at two markers that refine risk when a standard panel comes up short (2026 ACC/AHA dyslipidemia guideline).

Erectile Dysfunction Is Often Vascular Data, Not Just “Performance”

When a midlife man arrives with erectile dysfunction, the system tends to file it as a local problem — performance, mood, testosterone. The cohort data argue otherwise. Across prospective studies, men with ED run a higher future risk of cardiovascular events, coronary heart disease, stroke, and death, even after adjusting for the usual risk factors, with relative risks commonly between 1.3 and 1.6 for major outcomes (prospective cohort analyses; umbrella reviews). ED tends to arrive early, ahead of an event, not after it (narrative reviews).

The signal is strongest in William’s group. Risk runs higher in intermediate-risk men and in younger men in their 40s and 50s — the very men most likely to be reassured by a normal cholesterol and a quick calculator (mortality-focused meta-analysis). For them, ED is often the first sign the endothelium is falling behind, years before a conventional event.

That reshapes what an ED visit is for. A man in his 50s with new erectile dysfunction, central weight gain, and a family history of early heart disease deserves more than a phosphodiesterase inhibitor and a testosterone level. He deserves an honest cardiovascular look: blood pressure, fasting glucose and insulin, ApoB and Lp(a), and, in the right case, a coronary calcium score (advanced lipoprotein markers).

Not every case of ED needs a cardiac workup. But in a midlife man, it should stop being filed as a purely local complaint when his vascular system may be telling the truth first.

Why “Normal Cholesterol” Can Mislead

Cholesterol does not move through the blood on its own. It rides inside lipoprotein particles — and in many people, the number of atherogenic particles predicts arterial risk better than the cholesterol concentration does. A 2025 systematic review of discordance studies put ApoB ahead of both LDL-C and non-HDL-C as a risk marker (2025 systematic review).

LDL-C tells you how much cholesterol sits inside LDL particles. ApoB estimates how many atherogenic particles are carrying it. When the two agree, the standard panel works. When they diverge, the panel can read reassuring while particle burden runs high (recent discordance analyses).

Two men can share an LDL-C. One carries it in relatively few particles; the other spreads it across many more, often alongside insulin resistance or higher triglycerides. The cholesterol number matches. The arterial exposure does not.

So the sharper question is not whether your cholesterol is normal. It is how many atherogenic particles you carry, and what you inherited.

What ApoB and Lp(a) Add

Cholesterol is not the villain. It builds cell membranes, steroid hormones, bile acids, vitamin D, and the structure of nerves. Lipid therapy is not trying to erase it. It is trying to lower the number of ApoB-containing particles that can lodge in the artery wall (current dyslipidemia guidance).

Every atherogenic particle — LDL and VLDL remnants alike — carries a single apolipoprotein B. So ApoB counts the particles most able to do damage. LDL-C is the cholesterol in circulation; ApoB is how many potentially atherogenic vehicles are on the road.

William’s ApoB came back at 102 mg/dL — more particle burden than his routine panel implied, and above the roughly 80 mg/dL considered optimal for a man carrying added cardiovascular risk. His LDL-C looked acceptable. His particle count was not.

Then there was Lp(a), or lipoprotein(a). It is largely inherited, stays stable across life, and never appears on a standard panel unless someone asks for it. William’s measured 68 mg/dL, above the 50 mg/dL mark used to flag elevated risk. Guidelines now support measuring it once in adulthood, because it sharpens risk in ways nothing else on the panel can (ACC; AHA Lp(a) initiative).

His cholesterol panel read reassuring. His risk picture did not.

How to Actually Use ApoB and Lp(a)

Advanced lipids earn their place only when they change the decision in the room.

ApoB matters most when the story hints at discordance — a borderline LDL-C paired with higher triglycerides, central weight, prediabetes, or a strong family history of premature heart disease. In those patients, particle number and cholesterol concentration have often parted ways, and an ApoB moves the risk from uncertain to actionable (ApoB discordance literature).

What you do with it depends on context. For primary prevention without known disease, current guidelines set LDL-C goals under 100 mg/dL across low-to-intermediate PREVENT risk, and under 70 mg/dL at high risk. ApoB refines those calls, flagging people whose particle burden outruns their LDL-C, especially at an ApoB of 120 mg/dL or higher, or when several risk enhancers cluster (2026 multisociety guideline summary).

Lp(a) works differently. You measure it once, not repeatedly (National Lipid Association summary). An elevated level raises baseline risk for atherosclerotic events and aortic valve disease, argues for tighter LDL-C and ApoB targets, and justifies screening across the family, since the trait is inherited.

A borderline-risk man with a strong family history of early heart attack and a high Lp(a) is not the same patient as one with identical calculated risk and a normal Lp(a). In the first, the threshold to start a moderate-intensity statin, tighten blood pressure, and push harder on lifestyle is easier to cross.

For patients, the move is simple: if the numbers and the family story do not match, ask whether ApoB and Lp(a) have ever been checked. Your biology may be carrying information the basic panel never recorded.

What the Evidence Shows

Three points hold up.

ApoB catches risk that LDL-C misses when the two diverge, and in that situation it is the more accurate marker. Elevated Lp(a) is not a lab curiosity — it is an independent, causal driver of atherosclerotic disease and aortic valve disease, which is why guidelines now call for measuring it once in every adult. And lowering ApoB-containing lipoproteins reduces events in the right patients, particularly higher-risk people already on standard therapy (current guideline summaries).

None of that means every person with a normal LDL-C and a high ApoB needs aggressive treatment tomorrow. In primary prevention, baseline risk still governs. The USPSTF recommends a statin for adults 40 to 75 with at least one risk factor and a 10-year risk of 10% or more, and a more selective approach between 7.5% and 10% (USPSTF recommendation).

A normal panel can hide real risk, and treatment intensity still has to fit the whole patient. Both are true.

How the Guidelines Think About “Borderline” Risk

For people without known heart disease, the hard calls sit in the middle — not the low-risk 25-year-old or the high-risk 68-year-old, but the 45-year-old whose cholesterol looks fine on paper and whose calculator says “borderline.”

The USPSTF keeps it simple: for adults 40 to 75 without cardiovascular disease, a statin when there is at least one risk factor and a 10-year risk of 10% or more, and a more selective approach from 7.5% to 10%. Past 76, the evidence runs out (USPSTF recommendation).

The 2026 ACC/AHA multisociety guideline uses the newer PREVENT equations instead of the older pooled cohort equations, and layers risk enhancers on top (2026 guideline press release). PREVENT gives 10-year and 30-year estimates for adults 30 to 79 and sorts risk into low, borderline, intermediate, or high.

The enhancers tilt the call: family history of premature disease, chronic inflammation, high triglycerides, metabolic dysfunction, kidney disease, high ApoB, and elevated Lp(a).

Take a man at borderline or intermediate PREVENT risk who also carries a high Lp(a), a higher ApoB, central weight, and a sibling who had a heart attack at 52. The guideline frame supports treating him earlier and more assertively — a statin, tighter lipid targets, and often a coronary calcium score to see whether atherosclerosis is already underway (JAMA Cardiology editorial).

The rule is not that everyone at 7.5% gets a statin. It is that baseline risk, risk enhancers, family story, and advanced lipids belong in one conversation. When they line up toward higher risk, waiting for the first event stops being a neutral choice.

Why the Same “Normal” Doesn’t Mean the Same Thing

If two people can share an LDL-C and not a risk, the reasons are worth naming.

Insulin resistance, visceral fat, and higher triglycerides push the body toward more atherogenic particles without moving LDL-C much. Genetics shape both Lp(a) and the tendency toward discordance. Even the measurement matters — LDL-C is usually calculated, not measured directly, and the estimate drifts when triglycerides run high (ApoB review literature).

Your neighbor’s normal panel is not a verdict on your arteries.

It is also why both halves of modern medicine miss this. Routine care underuses ApoB, so hidden risk goes unmeasured. Aggressive longevity and functional practices overcorrect, treating every off-range biomarker as a disease. Neither reflex helps. Better measurement, then better interpretation, does.

HDL shows the trap. A low HDL is a useful marker, but raising it with drugs has not reliably reduced cardiovascular events in trials (systematic review and meta-regression). Low HDL is a reason to look upstream, not a target to chase.

Advanced Lipids Are Tools, Not Identity Labels

Advanced lipids can clarify risk. They can also be abused.

Conventional care errs by omission — never ordering ApoB or Lp(a) in the very patients whose stories point straight at discordance or inherited risk. The wellness and longevity world errs the other way, ordering enormous panels and treating every flagged line as its own disease.

The pattern is familiar. A patient arrives having had LDL particle number, oxidized LDL, Lp-PLA2, small dense LDL, and a fistful of proprietary scores measured. He has been told everything is wrong and put on a stack of supplements, a restrictive diet, and a schedule of expensive repeat testing. Strip it back, and the two signals that mattered were a high ApoB and a high Lp(a) — reachable with far fewer tests, and enough to guide real decisions about statins, lifestyle, and family screening (ApoB; Lp(a) consensus guidance).

The cost of over-testing is not only money. It turns biology into identity. Patients start describing themselves as oxidized-LDL types or particle-number types, even where those markers were never tied to outcomes the way ApoB and Lp(a) are. Risk becomes a brand. The nervous system burns its energy tracking panel changes instead of tracking whether the person is actually moving toward safer ground.

The honest use of advanced lipids is narrower. Order ApoB and Lp(a) when they will change a decision. Read them against guideline thresholds, family history, and the body in front of you. Then fold them back into the question that governs the rest of care: what, in this particular person, is happening that the standard instruments have only half seen?

What I Tell Patients in Clinic

When the routine panel looks acceptable but the picture does not, two measurements help: ApoB and Lp(a). ApoB estimates current particle burden. Lp(a) reveals inherited risk the standard panel will never show, and once in adulthood is enough (current guidance).

It earns its place when the numbers do not fit the person — a family history of early heart disease, central weight gain, prediabetes, higher triglycerides, or a vascular clue like midlife ED. There, a normal LDL-C is not the end of the conversation. It is where the better question starts.

When treatment is warranted, the answer is not always the most aggressive drug on the shelf. In primary prevention, baseline risk, tolerance, and preference still count, and shared decision-making belongs there.

William understood the science. He understood that his routine panel had not told the whole story. He still chose to wait, and I did not push him.

A more accurate risk picture does not force every patient to the same decision. It does force us to stop mistaking normal cholesterol for a finished cardiovascular assessment.

Questions to Bring Into the Visit

If your cholesterol looks fine but something still nags at you, these are quetions worth bringing to your next visit — 

1. “My cholesterol came back normal, so how do you actually know how likely I am to have a heart problem someday?” This nudges your doctor toward a real risk estimate with tools like PREVENT instead of a rough guess.

2. “Should we check my ApoB? With my triglycerides, my weight, and heart disease in my family, I’m not sure the regular cholesterol test tells the whole story.” ApoB can show particle risk a standard panel misses.

3. “Has anyone ever checked my Lp(a)? Heart trouble runs in my family, and I heard it’s a one-time test.” Current guidance supports checking it once in adulthood.

4. “If I’m kind of on the fence, what would make you lean toward starting a statin — and what would make you say let’s wait?” The USPSTF thresholds are a good anchor for that talk.

5. “Would one of those heart calcium scans actually tell us whether I need medication right now?” In in-between cases, the score often moves the decision one way or the other.

6. “Besides pills, what could I actually do that would move my numbers — my ApoB, my blood pressure, my weight?”

7. “If my ED might be an early warning for my heart, how do we take it seriously without going overboard on tests?”

That last one holds the ground the evidence supports: neither brushing the symptom off nor turning it into a sales pitch, but reading it as data.

If the panel looks fine but the picture does not, the goal is not more tests. It is the right two — and a more honest conversation about what they mean.

Enjoyed this breakdown?

The Life Beyond Labs series examines one health question at a time — without the hype in either direction.

For deeper clinical essays on what medicine often misses and what patients actually feel, subscribe to my Substack: Healing the Split

I publish there first, for readers who want more than a test result.

About the Author

Dr. Shiv Kumar Goel is a board-certified physician in internal medicine, functional medicine, and aesthetic medicine based in San Antonio, Texas. He brings over two decades of clinical experience to the intersection of conventional diagnostics and the lived reality of patients whose suffering resists easy measurement.

He is the author of What Medicine Misses and Patients Feel (forthcoming) — a clinically grounded, human account of the gap between what standard medicine can see and what patients actually experience.

To follow his work: drshivgoel.com To reach him directly: contact@drshivgoel.com

Patient details including name, age, timeline, and identifying circumstances have been changed. William is a composite drawn from clinical encounters over many years of practice. No individual patient is depicted or identifiable.

One day you wake up. Same walls. Same ceiling. Same people.

But something has shifted.

The place you have been calling home — you see it now as a cage.

Not because it changed. Because you did.

This is the moment no one warns you about. They talk about the breakthrough. The awakening. The turning point. They make it sound like freedom arrives with applause.

It doesn’t.

It arrives as a quiet, disorienting terror. The walls look the same. Your name is still on the door. The people inside still love you in the only way they know. But you can see the bars now. And once you see them, you cannot unsee them.

I have sat with this in my own life. I have watched it in patients.

The physician who has been practicing for twenty years and realizes she has been practicing someone else’s medicine. The son who has run the family business for a decade and wakes one morning knowing he was never meant to be there. The woman who has kept everything together and suddenly cannot explain why the keeping together feels like it is slowly killing her.

Good labs. Bad life. There’s a reason.

The reason is not weakness. It is not ingratitude. It is not crisis.

It is biology finally saying what biography never let you say.

The ones who feel caged do not become more caged when they start to see clearly. They were always caged. The clarity is not the problem. The clarity is the beginning.

The guards at the door — the ones who tighten their grip the moment you start asking questions — they are not your enemies. They are loyal to the only architecture they have ever known. Your seeing threatens their certainty. That is not malice. That is fear wearing the mask of care.

The reformers — the ones who arrive with the language of liberation and offer you a newer, cleaner cell — they are the most dangerous. Learn to feel the difference between the one who opens the door and the one who just moves it.

Here is the harder truth.

The prison was not built by your enemies. It was built by people who lived inside one too. They handed it to you as shelter. They called it home because it was the only home they had.

They created the split. You carried it without knowing.

This is what breaks open when I sit with a patient who is doing everything right and still feels like a stranger in their own life. It is not their failure. It is an inherited structure. The body is doing what biography asked of it — loyally, faithfully, until it cannot anymore.

The body does not malfunction. It escalates.

Not everyone who sees the prison wants to leave.

I want to be honest about that.

[Patient composite — all identifying details modified]

A man I’ll call Dev is in his late fifties. Spent his career in a demanding field that ran on hierarchy and protocol — you followed the chain, you did not question it. He came in a few months ago for insomnia. His wife had just passed. Over two decades together. No children.

I have known him for a while.

He is not a man who questions the architecture around him. He followed the rules. He built the life he was told to build. His wife, in her own quiet way, agreed with everything — which did not give him a mirror. It gave him an echo.

Now she is gone. And for the first time in his life, no one is telling him what to do next.

He told me his life is over.

He is on antidepressants. He is seeing a therapist. We are doing what the situation calls for.

But sitting with him, I heard something underneath the insomnia, underneath the grief. He is not lost because she died. He is lost because the warden just left.

The prison is all he has ever known. The walls are the only grammar he has for the word home.

I did not try to show him the door.

Some people are not ready for it. Some people, at this point in a life, need the walls to still be there. To take that from him — in the name of liberation — would be its own kind of violence.

I listened. I renewed his prescription. I told him to come back.

That is also medicine.

Out beyond ideas of wrongdoing and right doing,

there is a field.

I’ll meet you there.

— Rumi

So how do you leave, when you are the one who is ready?

Not by breaking harder. The more force you bring to the bars, the more the structure tightens around the force. That is not a metaphor. The HPA axis reads threat. The nervous system braces. The biology follows. You cannot heal in a body that is still bracing for impact.

You leave the way water leaves — through the crack that was always there.

The way of the whisper, not the shout. The inner knowing that was never lost. Only silenced. Only buried under the noise of the biography you were handed.

You never needed the map. You have the GPS built inside each fabric of yours.

The world outside does not reward you for leaving. No parade. No applause. For a while, the ones you love most will not understand. They may resist. They may grieve the version of you that stayed.

That is not your failure.

It is the natural consequence of becoming more clearly yourself in a space that was built around a smaller version of you.

I don’t know where you are reading this. Maybe at midnight. Maybe in the car after a long day when the house felt too quiet and too full at the same time. Maybe on a Sunday night when the weight of the week ahead feels like it belongs to someone else’s life.

But I know this.

The fact that you can see it — really see it — is not the problem.

It is the way.

The body has been waiting a long time. This is the first time you agreed to look.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography. He writes at healingthesplit.com.

Move more. Eat real food. Sleep. Don’t smoke. All true. All necessary. And it’s also where most people stop.

The patients who age slowly — the ones whose bodies look a decade younger than their charts — almost always do a few quieter things the headlines skip. None of these replace strength training or a decent diet. They sit on top of the basics, cost almost nothing, and target the parts of aging we usually ignore until they’re already gone: balance, metabolic flexibility, and the biological signal you can actually track.

These are the three I do myself, every morning, and prescribe to patients every week.

1. I Stand on One Leg While I Brush My Teeth

Why this matters

We spend enormous energy worrying about heart disease and almost none worrying about balance — until a fall happens. That is backwards.

Falls are among the most life-altering events in later life. They are a leading cause of injury-related death in older adults, and more than that, they are often the starting point for a cascade: a fracture, then immobility, then muscle loss, then the loss of independence that was never supposed to come this soon. What makes this particularly frustrating is that balance is not a fixed trait. It is a trainable skill, at any age. The nervous system and the muscles that hold us upright respond to practice the same way any other physical capacity does — if you ask them to work, they maintain. If you never ask, they quietly decline.

What the research actually shows

The one-leg balance test looks simple. It is not.

A 2022 study in the British Journal of Sports Medicine followed 1,702 middle-aged adults and found that those who could not hold a 10-second one-leg balance had an 84% higher risk of all-cause mortality over the following decade, even after controlling for age, sex, BMI, and underlying health conditions. That is not a minor signal. An 84% higher risk of death from failing a test that takes ten seconds to administer — a test that costs nothing, requires no lab, and can be done in a clinic hallway.

A separate longitudinal cohort study from the UK’s MRC National Survey of Health and Development followed over 2,000 adults from age 53 to 68. It found that those with consistently low balance scores at age 53 — before most chronic disease had declared itself — had more than three times the risk of recurrent falls by age 68 compared to those who could sustain balance for 30 seconds. That is a 15-year window between the signal and the consequence.

Balance is also one of the few measures that captures neuromuscular aging — the slow loss of coordination between the brain’s motor signals and the muscle’s capacity to respond — before it becomes visible. By the time a patient tells me they feel unsteady, the decline has already been building for years. The balance test catches it earlier, and earlier is when it’s still reversible.

What I do

Two minutes per leg, every morning, while I brush my teeth. I stand near the counter at first. Eyes fixed on one point. Breathing normal. I don’t rush it. Once 30 seconds feels easy, I increase difficulty: close the eyes for a few seconds to remove visual stabilization, or count backwards from a hundred to add cognitive load. That dual-task balance challenge mimics the real-world scenario — navigating a parking lot while thinking about something else — which is exactly when most falls happen.

If you haven’t done this in a while, start with eyes open and a hand available. The goal in week one is just to notice how it feels. Most people are surprised by how much harder it is than they expected.

2. I Take a 10-Minute Walk Right After I Eat

Why this matters

A great deal of what we call “aging” is accumulated metabolic wear — the slow damage that compounds from years of repeated blood sugar excursions after meals. Every time blood glucose spikes steeply and stays elevated, it drives a wave of low-grade inflammation, accelerates glycation of proteins and tissues, and adds to the biological debt the body has to service.

The most effective intervention I know for blunting those spikes is not a supplement. It costs nothing. It does not require a prescription. It is gentle movement in the thirty minutes after eating.

What the research shows

The data here is consistent across multiple populations and study designs.

A 2025 randomized crossover trial published in Scientific Reports found that a 10-minute walk taken immediately after a glucose load significantly reduced peak postprandial glucose and total glucose area under the curve, compared to both sitting and to a 30-minute walk taken 30 minutes after eating. The timing mattered as much as the duration. Walking immediately after the meal, while the gut was still absorbing glucose, produced a more effective glucose reduction than a longer walk taken later.

Earlier studies confirmed the same pattern in people with type 1 diabetes and in healthy adults, showing that post-meal walking reduces glucose excursions more meaningfully than pre-meal or fasted-state walking. The mechanism is relatively direct: muscle contraction during light movement increases glucose uptake by skeletal muscle through an insulin-independent pathway — GLUT4 transporter translocation — meaning blood sugar moves into cells whether or not insulin levels are high. This is particularly relevant for people whose insulin sensitivity is already declining, which describes most adults past their mid-thirties.

Over a year, over ten years, over two decades — smoothing those daily post-meal spikes is one of the most underrated things a person can do for their metabolic age.

What I do

Ten minutes, within thirty minutes of finishing a meal. No particular pace. No targets. I walk outside when I can; around the building when I can’t. After lunch is the highest-yield if someone only does it once a day — the post-lunch glucose response is often the largest of the three daily meals, and it hits during the hours when energy typically dips and people reach for coffee.

I tell patients: the meal ends, the walk begins. Not because you have time for it — make it the boundary. It takes the same time as checking your phone after eating. And it doubles as a stress reset, which is its own metabolic benefit.

3. I Track One Number So Aging Stops Being Invisible

Why this matters

Biological aging is quiet. It accumulates slowly, compounds for years, and rarely announces itself with a dramatic warning. Most of the patients I see with advanced metabolic dysfunction, elevated cardiovascular risk, or early chronic disease had normal labs five years earlier. Not because the labs were wrong — but because the labs they ran weren’t measuring what was actually moving.

The patients who change their trajectory share one behavior: they made aging visible. They picked one number that actually tracked their biological age — not their birthday — and they watched it move.

When aging is invisible, it is easy to postpone. When it has a value, it becomes a conversation you can have with yourself every three months.

What the research shows

hs-CRP (high-sensitivity C-reactive protein)

hs-CRP is a marker of systemic inflammation — the kind of sustained, low-grade inflammatory activity that damages blood vessels, impairs insulin signaling, accelerates cellular aging, and raises the risk of cardiovascular disease, diabetes, and all-cause mortality. A 2025 longitudinal cohort study in Archives of Gerontology and Geriatrics found that cumulative hs-CRP levels — even those below the traditional “elevated” threshold of 10 mg/L — were independently associated with increased all-cause mortality, mediated partly through blood pressure, fasting glucose, and uric acid. In other words, chronically elevated inflammation, even when it looks “normal” on a single lab draw, leaves a biological invoice.

The ACC/AHA guidelines identify hs-CRP ≥2.0 mg/L as a cardiovascular risk enhancer. In my practice, I watch trend lines, not single values. A patient whose hs-CRP was 0.8 two years ago and is now 1.7 is telling me something. They are not yet in “elevated” territory. They are moving toward it, and movement is the whole point.

ApoB (Apolipoprotein B)

ApoB is a better measure of cardiovascular aging risk than LDL cholesterol in most patients. Every atherogenic particle in the blood — including small dense LDL, IDL, and VLDL — carries exactly one ApoB molecule. Total ApoB therefore tells you how many atherogenic particles are circulating, not just their cholesterol content. Studies including the AMORIS study with more than 175,000 participants have shown ApoB to be a stronger predictor of fatal myocardial infarction than LDL-C. For a patient in their forties whose LDL looks acceptable but whose particle count is high, ApoB is the number that catches the risk that LDL misses.

Grip strength

This one surprises people.

Grip strength is one of the single most well-replicated predictors of all-cause mortality in medicine. A 2007 longitudinal study in The American Journal of Medicine followed nearly 5,000 adults for 30 years and found that grip strength in the highest quintile at baseline was associated with roughly half the mortality risk of those in the lowest quintile — a relationship that held for heart disease, stroke, and pneumonia, and remained significant after 20 years of follow-up. A 2022 meta-analysis of 121,116 adults across 29 countries confirmed the same dose-response relationship: every 5 kg increase in grip strength was associated with a 14% reduction in all-cause mortality and cardiovascular death.

What grip strength is measuring, indirectly, is the overall integrity of the neuromuscular system — the same system that governs balance, fall risk, recovery from illness, and the capacity to maintain independence into later life. It is not measuring hand strength alone. It is measuring how much biological reserve the entire system has.

You can measure it at home with a hand dynamometer for less than twenty dollars. You can recheck it every three months. It is more informative than most things on a standard annual panel.

What I do

I start patients on one number. Not four, not seven. One — the one that is most likely to be telling their particular story.

For someone with strong family history of cardiovascular disease or whose LDL looks acceptable but whose metabolic picture is unclear, I start with ApoB. For someone with vague fatigue, joint symptoms, or autoimmune risk, I start with hs-CRP. For someone whose primary concern is energy, blood sugar, and weight, I add fasting insulin alongside HbA1c — the two together reveal insulin resistance far earlier than HbA1c alone.

For patients who are skeptical about labs, I start with grip strength. Cheap. Immediate. Deeply predictive. Recheck it in 90 days. They always come back curious about the number.

Then we schedule. Every three to six months for labs. More often for home measures. Not obsessively — the goal is trend, not perfection. What gets measured tends to get managed. And what gets managed, over a decade, tends to matter.

A Word on What These Three Have in Common

None of these are glamorous. There is no device to buy, no subscription to start, and nothing to swallow.

They share a structural logic: they are all small signals sent to the body on a daily or weekly basis that remind it to stay capable of something. Balance practice tells the nervous system that proprioception and neuromuscular coordination still matter. Post-meal walking tells the metabolic system that it does not have to absorb glucose passively. Tracking a number tells the clinician — and the patient — that biological aging is being watched, not just assumed.

The patients who age well in my practice are not the ones doing the most. They are the ones doing the right things, consistently, before they needed to. Before the fall. Before the diagnosis. Before the number that was quietly moving finally made itself undeniable.

The goal was never just to add years. It was to make the years we add feel younger.

That is the real work of longevity medicine — and most of it still starts before breakfast.

Key Supporting Studies

Balance and fall prevention:

• Bergland A, et al. One-leg balance is an important predictor of injurious falls in older people. Age Ageing. 1997;26(2):123–130. [PMID: 9180669]pubmed.ncbi.nlm.nih

• Blodgett JM, et al. One-Legged Balance Performance and Fall Risk in Mid and Later Life. Am J Prev Med. 2023;64(3):e87–e95. [PMID: 36470757]sciencedirect+1

• Araújo CG, et al. Successful 10-second one-legged stance performance predicts survival in middle-aged and older individuals. Br J Sports Med. 2022;56(17):975–980.bjsm.bmj

• Cruz-Jentoft AJ, et al. Balance as an indicator of neuromuscular aging. Med News Today. 2024.medicalnewstoday

Post-meal walking and glucose:

• Shiraiwa T, et al. Positive impact of a 10-min walk immediately after glucose intake on postprandial glycemic control. Sci Rep. 2025;15:23161.nature+2

• Colberg SR, et al. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes. Diabetes Care. 2012. [PMID: 22875231]pubmed.ncbi.nlm.nih

hs-CRP and all-cause mortality:

• Tian Y, et al. Cumulative hs-CRP and all-cause mortality in middle-aged and elderly adults. Arch Gerontol Geriatr. 2025;135:105861. [PMID: 40354683]pubmed.ncbi.nlm.nih

• Blankenberg S, et al. Mortality risk prediction of high-sensitivity CRP. PMC8863282. 2022.pmc.ncbi.nlm.nih

ApoB and cardiovascular risk:

• Sniderman AD, et al. Age and Cardiovascular Risk Attributable to ApoB. Circulation. 2016. [PMC5121475]pmc.ncbi.nlm.nih

• Bonifacio E, et al. Significance of ApoB in elderly as predictive factor of cardio-cerebrovascular complications. Diabetes Res Clin Pract. 2009.sciencedirect

Grip strength and mortality:

• Sasaki H, et al. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med. 2007;120(4):337–342. [PMID: 17398228]pubmed.ncbi.nlm.nih

• López-Gil JF, et al. Longitudinal association of handgrip strength with all-cause and cardiovascular mortality. Exp Gerontol. 2022.sciencedirect

• del Pozo Cruz B, et al. Handgrip strength with all-cause and cancer mortality: 28 countries. Age Ageing. 2022;51(5):afac117. [PMID: 35639798]pubmed.ncbi.nlm.nih

• Taekema DG, et al. Prognostic value of handgrip strength in people 60+. Geriatr Gerontol Int. 2016. [PMID: 26016893]

About the Author

Dr. Shiv Kumar Goel, MD, is a internist and functional medicine physician in San Antonio, Texas. Trained at the Icahn School of Medicine at Mount Sinai, he is the founder of Prime Vitality Care and blends internal, functional, and integrative medicine to help patients align their health with their daily rhythms. He writes about longevity, stress physiology, and the reconnection of mind, body, and spirit in modern medicine.

She came in tired but matter-of-fact, the kind of fatigue you learn to carry without advertising. Mid‑forties, mid‑career banker, the sort of person whose life is built around other people’s anxieties about money. For three years, she had been waking up at 3:40 a.m. most nights—so consistently that she stopped needing the clock. It felt like her nervous system had set an alarm she hadn’t agreed to.

By the time she reached me, she had already done what most high-functioning patients do: supplements, devices, tracking. Melatonin. Magnesium. A sleek ring grading her sleep as if it were a quarterly report. The more she watched the numbers, the more anxious she became. Her scores dipped, and the story she told herself hardened: “I’m just a light sleeper. This is probably my age and my job catching up with me.”

On the surface, nothing was alarming. No major mood symptoms, no significant alcohol, no shift work. She went to bed around 10:30 p.m. She did “the right things” most sleep handouts mention. But when I asked her to walk me through the four hours before bed, not the five minutes before lights out, a different pattern appeared.

Dinner was often at 9 p.m., heavy and late, after a day of grazing and coffee. Lights in the kitchen and home office stayed bright and overhead long after dark, the kind of light that tells your brain it’s noon. The evening was full of unresolved tasks: emails half-drafted, deals half-closed, lists held silently in her head. Bedtime was not the end of the workday; it was where the workday got replayed.

I didn’t give her a new pill. Instead, we turned the focus to those four quiet hours before bed. We moved dinner earlier, aiming for at least a three‑hour window before she got under the covers—not as a rule to obey, but as an experiment in what happens when her body isn’t busy sorting out a late, heavy caloric load overnight. We lowered the angle and intensity of light: overheads off after sunset, warm lamps on, screens dimmed. And we created a small ritual for her mind: a handwritten list of unfinished tasks, followed by fiction that had nothing to do with banking, self‑improvement, or sleep.

Within a week, the 3:40 a.m. wake‑ups stopped. Not tapered, not “slightly better”—they simply didn’t show up. She still had stressful days. Markets still moved. But she no longer had the sense that her body was staging a nightly intervention. What changed wasn’t her diagnosis or her willpower; it was how food, light, and thought were arranged in the last part of the day.

Cases like hers keep pulling me back to a simple, unglamorous question: “Tell me about your evening.” Not the checklist of sleep hygiene tips, not the brand names of devices—but the lived, ordinary hours when your physiology is quietly deciding what kind of night you’re going to have. We talk a lot about insomnia as if it begins at bedtime. More often, it begins with the life that leads up to it

I think about her on the nights when my own patients tell me they’ve “tried everything” for their sleep. What they usually mean is that they’ve tried everything they can buy. The harder work is rearranging the hours that don’t look like medicine at all—the late dinner, the overhead light, the mental to‑do list we mistake for productivity. If your body keeps waking you at the same time night after night, it may not be punishing you; it may be pointing to the part of your day you’ve decided is non‑negotiable.

Healing the Split is a reader-supported publication. If you’d like more essays on sleep, stress physiology, and the stories patients tell themselves about being “high‑functioning” while exhausted, you can subscribe for free or choose a paid subscription to support the work. Paid readers help me carve out protected time for this kind of slow, narrative medicine—clinic stories that don’t fit in a 15‑minute visit or a lab report.

Subscribe now

Author bio

Dr Shiv Kumar Goel is a physician and functional medicine specialist based in San Antonio, Texas, who writes about the split between how people look on paper and how they actually feel. He practices at Prime Vitality Care and is the author of Healing the Split, a newsletter on symptoms, stories, and the quiet physiology of everyday life.

For three years I woke up at 3:40 in the morning. Not occasionally. Most nights, close enough to the same minute that I stopped looking at the clock, because looking made it worse.

I assumed it was age. I was in my mid-forties, I had a practice to run and a book in progress, and 3:40 felt like the invoice for that. Every physician I know has a version of this story, where we diagnose ourselves with something vague and move on, because the alternative is taking our own advice.

What it turned out to be had almost nothing to do with what I was doing at bedtime. It had to do with the four hours before it. I changed three things across that window and the 3:40 wake-up stopped. It has not come back.

I’m an internist, and I now ask every patient who tells me they can’t sleep to walk me through their evening rather than their bedtime routine. The answer is nearly always in the earlier part.

1. Moving the last meal earlier than felt reasonable

I used to eat at 8:30 or 9, because that’s when the day was actually over. Then I’d be in bed by 10:30 wondering why I felt warm and restless.

The study that reorganized my thinking here is a small, tightly controlled crossover trial out of Johns Hopkins, published in the Journal of Clinical Endocrinology and Metabolism in 2020. Twenty healthy young volunteers, ten men and ten women, spent two separate stays in a research unit eating the identical meal at either 6 PM or 10 PM, with a fixed 11 PM bedtime and blood drawn hourly through the night.

Same food. Same calories. Same people.

The late dinner produced a peak glucose roughly 18 percent higher, and overnight fat oxidation dropped by about 10 percent. Plasma cortisol went up. The effects were most pronounced in people who habitually went to bed earlier, which is to say the people for whom 10 PM was genuinely late relative to their own clock.

That’s a single meal, in healthy twenty-somethings, measured over one night. I want to be careful not to inflate it. But the authors’ framing is the part I quote to patients: if these effects recur chronically, they plausibly contribute to obesity and glucose dysregulation. Most of us are not eating one late dinner. We’re eating four hundred of them a year.

The mechanism also explains the 3:40 specifically. A large late meal drives a glucose rise and then a compensatory fall in the early hours, and that fall triggers a counter-regulatory cortisol and catecholamine response to pull blood sugar back up. That response wakes you. Separately, core body temperature has to drop for deep sleep to consolidate, and digestion is heat-producing work that runs directly against it.

I moved dinner to 6:30. Three hours before bed is the number I use with patients, and it produced the fastest effect of anything I changed. Not gradual. The first week.

The pushback is always about family schedules and about not being hungry at 6:30, and both are legitimate. When someone truly can’t move dinner, I tell them to move the size instead. A smaller late meal behaves differently than a large one. It’s not as good as an earlier one. It’s not nothing.

2. Cutting overhead light after sunset

This is the one that sounds like wellness theater. It is the best-evidenced item on the list.

Gooley and colleagues at Brigham and Women’s and Harvard published a study in the same journal in 2011 in which participants lived in a research center for at least five consecutive days under controlled lighting. Ordinary room light in the hours before bed, the kind in every kitchen in America, shortened the duration of melatonin production by roughly 90 minutes compared to dim light. Room light during habitual sleep hours suppressed melatonin by more than 50 percent.

Ninety minutes. From the ceiling.

The reason this happens is that melatonin release is gated by specialized retinal cells that care about intensity, wavelength, and crucially the angle light arrives from. Light coming from above, which is what every overhead fixture produces, reads to that system as midday sun.

I did not want to believe this mattered as much as it does. I put lamps at eye level and below in the rooms I actually use after dark, switched to warm bulbs, and stopped touching the overheads. My wind-down went from something I had to manufacture to something that arrived on its own around nine.

What I tell my patients: you don’t need candlelight. You need to stop being lit from above after sunset. It’s a lighting change, not a lifestyle change, and it costs about sixty dollars.

The screens matter too, but less than people assume and much less than the ceiling. A phone is a small light source six inches from your face. A kitchen ceiling is a large one filling your entire visual field.

3. The wind-down I resisted for years

Here’s the one I fought hardest.

I did not want an evening routine. It struck me as something for people with more time than I had, and there’s a version of it circulating now that’s so elaborate it becomes another job. If your wind-down has nine steps, you haven’t solved your sleep problem. You’ve given yourself homework.

What I eventually adopted takes twenty minutes and has two parts: I write down whatever is unfinished, on paper, in a list I don’t organize or prioritize. Then I read fiction.

The writing half has better evidence than I expected. Scullin’s group at Baylor published a polysomnography study in the Journal of Experimental Psychology in 2018 with fifty-seven adults who spent five minutes before bed writing either a to-do list for the coming days or a list of tasks already completed. The to-do list group fell asleep measurably faster. And the more specific and detailed the list, the faster they fell asleep, which is the opposite of what you’d predict if writing about unfinished work simply stirred up worry.

The interpretation the authors favor, and the one that matches my experience, is offloading. The tasks don’t get done. The brain stops rehearsing them because they’ve been externalized somewhere reliable.

It’s fifty-seven young adults on a single night in a lab, so I hold it loosely. But it costs five minutes and a piece of paper, and I’ve now watched enough patients report the same thing that I ask about it routinely.

The fiction half has no trial behind it and I won’t pretend otherwise. It’s a boundary. I needed something my mind could not usefully continue at three in the morning, and medical journals failed that test badly.

What didn’t work, despite the hype

I want to name what I tried first, because I spent money and about eighteen months before I addressed anything above.

Melatonin supplements did essentially nothing for me, and in hindsight that’s unsurprising. Meta-analyses of melatonin for sleep onset show a genuine but small effect, on the order of several minutes. My problem was not a melatonin deficiency. It was a melatonin timing problem, created at 7 PM by my kitchen ceiling, and a three milligram tablet at 10 PM does not fix a signal that was already scrambled.

A sleep tracker made things actively worse for a while. There’s a recognized phenomenon here, named orthosomnia by Baron and colleagues in 2017, in which the pursuit of perfect tracked sleep produces the anxiety that then degrades sleep. I became a person who woke and immediately checked a score, and on nights the score was poor I felt worse than the sleep itself warranted. I took a two-month break from the ring and slept better during it.

Magnesium helped a little. I still take it. It’s a modest assist on top of a fixed foundation, and I had the order backward for a year and a half.

Start with the earliest one

If you change one thing, change the earliest one in the day.

That’s the principle I’ve landed on. Evening problems compound forward. A late meal makes the light exposure matter more, and both make the wind-down harder, and by the time you’re lying in bed doing breathing exercises, you are trying to solve at 10:45 a problem that was created at 6:30.

So move dinner. Not by three hours, not perfectly, not every night. Move it ninety minutes for two weeks and watch whether the hour you keep waking at changes.

Mine moved to 5:15, which was still annoying. And then it stopped.

If the four hours before bed are quietly breaking your sleep, you’re not alone. In this essay I walk through three small evening changes—earlier dinner, dimmer light, and a paper wind-down—that stopped a 3:40 a.m. wake-up that had followed me for years

Dr Shiv Kumar Goel is a board-certified internist practicing functional and integrative medicine at Prime Vitality Care in San Antonio, Texas. Follow his Substack, healingthesplit, for more of his writings.

References

• Gu C, Brereton N, Schweitzer A, et al. Metabolic effects of late dinner in healthy volunteers: a randomized crossover clinical trial. J Clin Endocrinol Metab. 2020;105(8):2789–2802.

• Gooley JJ, Chamberlain K, Smith KA, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011;96(3):E463-E472.

• Scullin MK, Krueger ML, Ballard HK, Pruett N, Bliwise DL. The effects of bedtime writing on difficulty falling asleep: a polysomnographic study comparing to-do lists and completed activity lists. J Exp Psychol Gen. 2018;147(1):139–146.

• Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351–354.

She did not book an appointment to talk about her life.
She booked it for peptide therapy.

Reverse the aging. Fix the joints. Optimize the labs.
She arrived with that specific, polished ask, the way high‑functioning patients often do.

She had done her research — PubMed, blogs, podcasts, all cross‑indexed in her mind.
She could quote trials, list side effects, and explain mechanisms of action more fluently than some residents I’ve trained.

Halfway through her intake, she mentioned the zoledronic acid.

“Mild osteoporosis,” she said. “Some side effects.”
Her tone was flat, as if she were reading from someone else’s chart.

I wrote it down, but not because of the bones.

When someone accepts that much pharmaceutical intervention for that little disease burden, it is almost never about the T‑score.

She did not bring a physical folder into the room.
Her folder was internal — tabs already color‑coded.

Insomnia.
Anxiety.
Always at the edge.
The pressure to look perfect.

She named each item with the precision of a cardiologist calling out EKG leads: V1, V2, V3 — except her leads were dermatology, endocrinology, OB‑GYN, psychiatry, and therapy.

She had five different clinicians, each holding one sliver of the same nervous system.
Five separate conversations about five separate pieces of the same person.

“I’m probably a carbon copy of my mother,” she said.
Then, almost in the same breath: “We haven’t spoken in a while.”

No catch in her voice. No softening.
Just the report: an emotional biopsy that had long since been fixed in paraffin and labeled “old news.”

Her mother was anxious, always on the edge, the way she is now.
The same hypervigilant wiring passed down like eye color, except no one ever named it as inheritance.

Her father “was there,” she said, “we’re just not that close.”
Again, six words, zero affect.

Her children now live in different states.
She is single.
The pattern is clear from the outside; it had not yet broken through from the inside.

She spoke in full paragraphs.

No hesitations. No searching for language.
She anticipated my questions and answered them before I could open my mouth.
She knew the clinical vocabulary, the generational thread, the HPA axis, and the word “epigenetic.”

She knew everything.

And somewhere in the telling and retelling of her life, she had stopped actually hearing herself.

Sitting in that exam room, I noticed something I rarely name explicitly:
There was no silence.

Not one pause she did not immediately fill.
Not one question she allowed to hang unanswered for more than a second.
She was talking faster than the silence could catch up.

This is a gap medicine does not have billing codes for.

It is not the gap between symptoms and diagnosis.
It is not even the gap between subjective distress and “normal” labs.

It is the gap between accurate self‑knowledge and actual change.

She could map the inheritance two, three generations back.
She understood what chronic vigilance does to cortisol, sleep architecture, and connective tissue.
She had the map.

But knowing the biography is not the same as rewriting it.

The body does not keep score of what we understand.
It keeps score of what we allow ourselves to feel.

From a purely medical standpoint, I could have stayed on the surface.

Order labs.
Adjust hormones.
Optimize peptides.
Tighten up her supplement stack.

And I did some of that.

I reviewed her zoledronic acid history and told her — gently — that in my view it was more intervention than her bone density warranted.
We sketched out a reasonable plan for peptide therapy, acknowledging both the benefits and the limits.

But the more important intervention was upstream.

She did not need another molecule before she had at least one room in her life where she could stop performing the knowing.
One room where her job was not to present the polished, coherent narrative of her suffering — but to risk the awkward, disrupted silence of actually feeling it.

I asked her one question no one had asked her before.
I am still not sure if she heard it.

On paper, the plan she left with looked a lot like what she had received before: labs, follow‑up, therapeutic options.
The difference was not in the complexity of the protocol.
It was in the question underneath.

Do you want to keep narrating this life from just above it, or are you willing to come down into the body that is paying for it?

Because here is the quiet truth we rarely say out loud in clinic:

Insight is not always the door.
Sometimes insight is the lock.

As physicians, we have built exquisite tools for naming what is wrong — imaging sequences that see millimeters, biomarkers that measure nanograms, pharmacology that targets receptors with surgical precision.
We have far less training for what to do when a patient already knows exactly what is wrong and uses that knowing to stay exactly where they are.

We say, “Can’t help someone who doesn’t want to be helped.”
But she kept making appointments. She kept walking through doors.

People who have truly stopped looking do not do that.

So this is not a story about a “noncompliant” patient.
It is a story about sequence — about what happens when we jump to the molecule before we sit with the silence.

For the patient who recognizes themselves in her:

If you have told your story to multiple clinicians, multiple therapists, multiple friends, and nothing in your life has moved, the problem may not be that no one is listening.
It may be that you have learned to talk just fast enough to stay ahead of the silence that terrifies you.

The work is not to explain your life better.
The work is to risk one room — with a clinician, a therapist, a trusted witness, or even with yourself — where you stop explaining and let your body answer back.

All identifying details in this case have been modified.

Dr Shiv Kumar Goel is a physician writer and functional medicine specialist exploring where biology, story, and silence meet. He works at the intersection of longevity, trauma‑informed care, and the quiet ways the body keeps score.

She came for peptide therapy.

That was the request. Reverse the aging. Fix the joints. She had done her research — the way she did everything — thoroughly, fluently, with full command of the literature.

She mentioned the zoledronic acid almost in passing. Mild osteoporosis, she said. Some side effects. She said it the way she said everything. Like a fact that had already been processed, already filed.

I wrote it down.

Because when someone accepts that much intervention for that little disease, the question is almost never about the bones.

She came in with a folder.

Not a physical folder. The folder was in her mind. Every tab labeled. Every section indexed.

Insomnia. Anxiety. Always at the edge. The need to look perfect. She named them the way a cardiologist names leads on an EKG — precisely, without flinching.

She had an OB-GYN, a dermatologist, a PCP, an endocrinologist, and a therapist. Five physicians. Five separate conversations about five separate pieces of the same person.

She had done the work. She had read the chapters. She had named the inheritance.

“I’m probably a carbon copy of my mother,” she said. Then, almost in the same breath: “We haven’t spoken in a while.”

She said it flat. Not grieving. Not angry. Reported.

The way you report a fact you stopped feeling a long time ago.

The mother was not easy. Anxious. Always at the edge — the same edge. The same nervous system, passed forward without anyone choosing to pass it.

The father was there. Physically. But not really there.

She described him in six words: “Yeah, we are just not that close.”

No catch in her voice. No pause. Just the flat geography of a distance she had stopped trying to cross.

She is single now. Her children live in different states.

She knew the pattern. She just hadn’t let it touch her yet.

She talked in full paragraphs.

No searching for words. No visible confusion. She anticipated questions and answered them before I could ask. She knew the clinical language. She knew the generational thread. She knew what the body does when it grows up inside a nervous system that never learned to rest.

She knew everything.

And somewhere in the telling and the telling and the telling, she had stopped hearing it herself.

I felt it clearly in that room. She had been telling her story to everyone. But not really hearing it deeply enough to understand.

That is what I sat with.

The story was not the problem. The story was correct. The problem was that the story had become the container — and the container had become the limit.

She was narrating her life from just far enough above it that she could not feel the ground.

I noticed something I rarely notice. There was no silence in that room. Not one pause she didn’t immediately fill. Not one question she left open.

She was talking faster than the silence.

And I did not know — sitting there — if she would ever let one in.

This is the gap medicine almost never names.

Not the gap between symptoms and diagnosis. Not the gap between what a patient feels and what the labs show.

The gap between accurate self-knowledge and actual change.

She could narrate the inheritance. She could trace it one generation back, two generations back. She knew the word epigenetic. She understood what chronic vigilance does to the HPA axis. She had the map.

Your symptoms are not random. They are your biography written in your biology.

But knowing the biography is not the same as rewriting it.

The body doesn’t keep score of what you understand. It keeps score of what you feel.

I want to be honest about the peptide request.

I prescribe these therapies. I use some of them myself. They are real molecules with real biology. This is not a story about a patient who was wrong to ask.

It is a story about sequence.

She wanted to reverse age. Fix the joints. Restore the surface. She had already done this with everything else — a specialist for each piece, a molecule for each complaint, a framework for each pattern.

Each piece in its own box. Each box handled. None of them adding up to a person who could sit in a quiet room without filling it.

She did not need another molecule before she had one room in her life where she could stop performing the knowing.

That was the upstream. And the upstream is always where the answer lives.

I did not tell her this in those words.

I ordered labs. I reviewed the zoledronic acid — it was, in my view, more intervention than her bone density warranted, and I said so carefully. I asked one question she had not been asked before. I do not know if she heard it.

She left with a plan. It looked, on the surface, like most of what she had been given before. The difference was not in the complexity.

It was in the question underneath.

Can’t help the one who doesn’t want to be helped. I have felt that before. But she came. She kept making appointments. She is still walking through doors.

People who have truly stopped looking do not do that.

I want to say something to the physicians reading this.

We have built extraordinary tools for naming what is wrong. Better imaging. Smarter biomarkers. More precise pharmacology. We have almost no practice for what to do when a patient already knows what is wrong — and has learned to use that knowing to stay exactly where they are.

Insight is not always the door. Sometimes insight is the lock.

And for the reader who sees themselves in her:

If you have told your story many times and nothing has changed, the problem may not be that no one is listening.

It may be that you have learned to talk just fast enough to stay ahead of the silence.

The work is not to explain your life better.

It is to risk one room where you stop explaining — and let your body answer back.

All identifying details have been modified.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com. His work appears in KevinMD, Op-Med, Medium, Elephant Journal, and San Antonio Medicine.

Subscribe now

We’ve spent a century learning how to live longer. The harder question is how slowly we can age.

She was thirty-four. She had run a half-marathon the spring before. She ate the way the magazines tell you to, and her intake form had nothing worth circling. She came in for a few weeks of symptoms she’d filed under stress. The colonoscopy said otherwise. (PATIENT — COMPOSITE, all identifying details modified; no single real patient is depicted.)

She was, by every metric, fine. That is the part I keep returning to.

Two decades ago, a chart like hers would have stopped a hallway full of clinicians. We’d have called it a fluke and moved on. The diagnosis still lands like a blow. But it no longer surprises me the way it once did, and that shift — from unthinkable to ordinary — happened inside a single career. Mine. It leaves a question I can’t put down. If our genes haven’t changed in a generation, why are the diseases of old age arriving early?

The number on the cake isn’t the number that matters

There are two ways to count a life. The first is easy. The candles. The count of birthdays. Chronological age is honest but shallow. It tells you how many times the earth has circled the sun while you were alive. It tells you nothing about the body that did the orbiting.

The second count is biological age. How worn or how resilient your cells and systems actually are, after years of absorbing your genetics, your habits, your environment, and a thousand exposures you never noticed. Two people can blow out fifty candles on the same afternoon and live in entirely different bodies. One carries the physiology of a younger person. The other is already weathered.

This is the gap I have spent twenty years inside. Good labs. Bad life. There’s a reason. The cake doesn’t know the difference. Increasingly, the science does.

What the evidence shows, and what it doesn’t

A study published this June in Nature Medicine sharpens the intuition. Researchers at Washington University drew on 154,169 adults in the UK Biobank, with validation in a separate US cohort, and measured biological aging with a clock called PhenoAge. People born in more recent decades aged faster than those born earlier. Those born between 1965 and 1974 carried a biological age gap roughly 23% higher than people born in the early 1950s. And a faster pace of aging tracked with solid cancers diagnosed before fifty-five — driven by lung, gastrointestinal, and uterine cancers.

The detail that holds me is organ-specific. When they looked tissue by tissue, an aging immune system tracked with early-onset lung cancer, and an aging adipose system — the body’s fat tissue — tracked with early-onset colorectal cancer. Not the whole body aging at once. A particular system, escalating ahead of the rest.

It’s worth being precise here, because precision is where most health writing gets lazy. This is an association, not a verdict. The study does not prove accelerated aging causes cancer. It shows the two travel together, and the effect, per standard deviation, is modest. “Biological age” isn’t one thing either. It’s a family of clocks, and they don’t agree. This one leaned on PhenoAge, built to predict mortality and clinical risk rather than just birthdays, and confirmed the signal with two independent measures. Knowing which ruler was used is the difference between a finding and a feeling.

Still, associations are how medicine finds its way. They tell us where to dig. This one points somewhere uncomfortable.

Progress arrives with a hidden invoice

The study doesn’t hand us a villain. No single toxin to ban. No one gene to blame. Accelerated aging looks instead like the sum of small, patient pressures. Chronic inflammation, broken sleep, processed food eaten at all hours. The long sit, the ambient dread, the disrupted gut. Each one is modest. In aggregate they are the slow accumulation of small inflammations that I have watched age people, biomarker by biomarker, year by year.

None of this is new. What’s new is how thoroughly it’s been woven into ordinary life. Every advance that made living easier also made it easier to sit still, sleep badly, and eat from a wrapper. Progress arrives with a hidden invoice. The convenience is charged to the body, and the bill comes due quietly, years before anyone reads it aloud in an exam room.

Here is where I refuse the easy story

This is the moment the wellness economy steps in with its list. Move more. Eat real food. Sleep. Drink less. Manage your stress. The list is not wrong. I use a version of it in my own practice, on my own body.

But it’s also where the wellness industry cheats, and where medicine fails the same patient from the other side. The industry sells the list as willpower, in fourteen-day and thirty-day cycles, as if biology kept a calendar. Medicine, meanwhile, waits downstream, treating the diagnosis once it arrives and rarely asking what upstream let it.

My half-marathoner had already done the list. She was hyper-compliant, with the wrong map. Every number anyone routinely checks came back reassuring — her weight, her glucose, her HbA1c. But her fasting insulin was 22. Her hsCRP wouldn’t settle. Her cortisol, low in the morning the way it should be, refused to come down at night. When I asked about her gut, she said no. Then, almost as an afterthought: just some episodic diarrhea and acidity, lifestyle and her periods, she guessed. None of it was a diagnosis. All of it was a body escalating.

The wellness version would have told her to try harder. The conventional version told her she was fine, until she wasn’t. She didn’t need more discipline. She needed someone to take both her normal labs and her wrong instinct seriously at the same time. That is the work. Not picking a team. Finding out what is actually happening inside this specific person.

The clock is not the calendar

Here is the hinge the whole story turns on. Biological age, unlike the candle count, is not fixed. The processes that drive it are responsive — to movement, to real food, to restorative sleep, to less alcohol, to managed stress. Not as moral instructions. As levers that move many systems at once.

They don’t merely lower the odds of one disease. They appear to slow the accumulation of damage itself. And for the first time we can begin to measure it. Newer clocks, like one called DunedinPACE, were built precisely to track the pace of aging as it responds to how a person lives. I can watch a fasting insulin of 22 come down, an hsCRP settle, a cortisol curve learn to fall again at night. That turns vague worry into something a patient can see. What people can see, they can change.

The question for the century

So I find myself less interested in the old triumph than in the new task. Medicine got extraordinarily good at the first job. Keeping people alive longer. We added the years. The harder, less photogenic work now is making sure those years are lived in a younger body.

If younger generations really are aging faster than their parents, then the defining health question of this century is no longer how long we can live. It’s quieter than that. How slowly can we age — and are we willing to read the hidden invoice before it’s too expensive to pay?

I think back to my thirty-four-year-old. The lesson of her chart wasn’t despair. It was urgency, and a strange consolation. The clock we’re worried about is one we can still, in part, slow down. Her biology was fighting her biography. The candles never knew.

Primary source: Tian et al., “Biological aging and generational shifts in early-onset cancer risk,” Nature Medicine (2026), doi:10.1038/s41591-026-04448-w. Supporting work: Belsky et al., “DunedinPACE,” eLife (2022); Sylvester/University of Miami research on biological age acceleration and colorectal polyps in adults under 50 (Cancer Prevention Research, 2024).

Dr. Shiv Kumar Goel, MD, is a board-certified internal and functional medicine physician in San Antonio, founder of Prime Vitality Care, host of the Healing the Split podcast, and author of the forthcoming Healing the Split. He writes on the body-mind-consciousness frontier of modern medicine.

I have always laid my cards down flat.

Every one of them. Face up. Nothing tucked away in a sleeve, no strategy, no performance. Just the full hand — spread wide across the table for anyone willing to look.

And yet.

They squint. They hesitate. They circle slowly, convinced there must be a trick somewhere. Because surely, no one is this open. Surely, transparency this complete must be concealing something.

So they lean in and begin to read.

But not my cards. Their own.

Every line they trace is a fear they never named out loud. Every meaning they extract is a story they have been carrying — pressed tight against their own chest, never shown to anyone. They read their secrets and call them mine. They hear their own voice and think it is my confession.

I was not bluffing. I was simply the only one at the table who stopped pretending.

I am an open book — always have been. Every page turned, every chapter bare. No locked rooms, no torn-out entries, no careful editing of the parts that do not look good in daylight.

So why does no one read me?

The ones who try — they skim. They scan for what they already expect to find, recognize the familiar, skip the rest, and call it understanding. They do not read my words. They read their own translation of them — filtered through their fears, their projections, their unresolved stories — and hand it back to me as if it is mine.

This, I have come to understand, is the cruelest irony of openness.

You lay everything down and discover that most people do not know how to read something that is not written in their own language. Transparency is not enough. It never was. The reader has to be willing to set down their own story long enough to receive yours.

Most are not willing.

She came in with everything already organized.

Every symptom dated. Every prior diagnosis labeled. Every medication, every reaction, every physician she had seen over fourteen years — laid out in a document she had written herself, printed and brought to the appointment.

Fourteen years. Eleven physicians.

She had been transparent with every one of them. More than transparent. She had done the work most patients never do. She had named the pattern before anyone asked. She had connected the fatigue to the insomnia, the insomnia to the anxiety, the anxiety to the year her mother died, and the year her mother died to the decade that followed — the one she described as living at half-volume.

Nobody had slowed down long enough to receive it.

They read the labs. They adjusted the medications. They treated each complaint as its own event — a separate chapter in a book they never bothered to open.

One physician told her she was too focused on her symptoms. Another told her the anxiety was driving everything. A third ordered more tests and never followed up.

She was not complicated. She was clear. She had done the translation for them. She had handed them the map, labeled and legible, and they had filed it away and looked instead for what they already knew how to find.

What it cost her was fourteen years. And a particular kind of exhaustion that is different from tiredness — the exhaustion of being present, fully available, and still invisible.

What changed when I slowed down was this: I read what she actually wrote.

Not the labs. The document. Her document. The one she had brought to eleven appointments before mine.

I asked two questions nobody had asked. She answered in one sentence each. We sat with both answers for a moment.

She said: Nobody has ever just let it sit there before.

I said: I know.

All identifying details have been modified.

I have sat with hundreds of people in their most vulnerable moments. And I have noticed something quietly devastating. The most transparent people in the room are often the most misunderstood.

Not because they are complicated.

Because depth requires the reader to slow down. To set aside their own narrative for a moment. To actually listen, rather than interpret.

Most people never do.

They are too busy holding their own deck tightly against their chest — reading their hidden cards so loud inside their own heads that they mistake their own reflection for someone else’s truth.

Your symptoms are not random. They are your biography written in your biology.

The first failure — before any lab, before any scan — is often this: no one actually read the book the patient laid open on the table.

There is a particular kind of loneliness that belongs only to the truly open.

It is not the loneliness of isolation. It is worse.

It is the loneliness of presence — of being right there, fully available, wide open — and watching people look straight through you. Or worse, look at you and see only themselves.

I know this loneliness from inside the clinic. I know it from inside my own life.

The split between who you are and how you are received — that is a real fracture. It accumulates slowly, quietly, in the way that small inflammations accumulate over years before they finally become something a test can measure.

The body does not malfunction. It escalates.

And so does the silence around the person no one learned to read.

This is why I write.

Not because writing guarantees being understood. It does not.

But because the page receives what people often cannot. It holds exactly what you give it. It does not translate, filter, or hand it back misread. The words stay where you put them. They do not rearrange themselves into someone else’s story while you are not looking.

Writing does not misunderstand you.

And maybe that is enough — to be witnessed, even if only by yourself. To name the thing. To lay the card down. To say this is real, this happened, this is who I am — and let it exist somewhere outside the silence.

Write it down.

Dr. Shiv Kumar Goel, MD, FACP, is a board-certified internal and functional medicine physician in San Antonio, founder of Prime Vitality Wellness®, host of the Healing the Split podcast, and author of the forthcoming Healing the Split: When Your Biology Is Fighting Your Biography. He writes at healingthesplit.com.

Subscribe now

She used the word failure the way some patients use the word diagnosis—as if someone with more authority had already confirmed it. She had lost forty pounds on Ozempic. She regained all of it in eleven months, the same month her insurance stopped covering the prescription.

She didn’t say her coverage lapsed.
She said she failed.

I didn’t correct her right away. Corrections land differently when someone finally hears themselves say the wrong thing out loud, in a room where another human being is prepared to disagree.

This is not an argument against the drug. Ozempic, Wegovy, Mounjaro—GLP‑1 receptor agonists—are among the most effective tools medicine has produced in decades. I prescribe them often. I will continue prescribing them.

The molecule is not the problem.
The problem is everything we never built around it.

The Silence No One Warned Her About

On paper, she did exactly what the drug is designed to do. GLP‑1 agonists act on receptors in the hypothalamus and hindbrain—the regions that register fullness and food reward long before conscious willpower gets a vote.

Her labs were pristine. Fasting glucose, A1c, lipids—textbook. The scale moved forty pounds in the right direction. By every metric medicine is trained to track, this was a success story.

But her labs never captured what stopped the moment the drug started working.

For eleven months, she told me, the noise went quiet. She used that word before I did. The constant negotiation over when she’d eat next. The low hum of food thoughts she’d carried since her twenties. Gone.

She didn’t miss the forty pounds nearly as much as she missed the silence.

She is not the only patient who has credited this drug for a quiet it never explained.

The Weight We Don’t Measure

A man in my practice lost forty pounds in five months. He celebrated the number before he came back to see me. A quarter of that weight was muscle.

No one had measured his muscle mass before he started, so no one could tell him what he was trading away while the scale kept dropping. When I finally checked his body composition and showed him the split between what he lost and what he thought he lost, he went quiet in a different way.

“I thought I was getting healthier the whole time,” he said.

He had gotten thinner.
Those are not always the same sentence.

Muscle is not vanity tissue. It determines how well he will walk at seventy, how well he clears glucose at fifty, whether a fall at eighty ends in a bruise or a fracture. Losing a quarter of forty pounds as muscle is not a cosmetic footnote. It is a silent decision—made by a drug and an unmonitored deficit—about what kind of body he will inhabit in twenty years.

A decision no one asked him to make.

The Appetite That Disappears Too Well

Another patient has not eaten enough protein in eight months to maintain the body she has left. No one told her that appetite suppression this strong requires a deliberate plan to eat against it—not simply less of everything.

She does not lack discipline.
She lacks a target no one gave her, for a problem no one named.

The drug changes what the body is asking for today.
It does not tell you what the body was asking for the thirty years before that.

That is the split.
Good labs. Bad life. And there’s a reason.

What Food Noise Was Doing All Along

Food noise that runs for decades does not appear out of nowhere. Somewhere in that span, it was doing something—regulating a low-grade anxiety that had nowhere else to go, filling a specific kind of evening silence, giving a pair of hands something to manage while a marriage, a job, a grief needed managing and food was the only variable within reach.

The receptors GLP‑1 drugs quiet are neighbors to the brain’s reward circuitry. Appetite and dopamine-linked craving share real estate. Turning down one can turn down the other. For a while, that feels like relief instead of erasure.

But quieting a signal chemically is not the same as resolving whatever built it over thirty years. The signal returns the moment the chemistry stops.

It returned for her at month eleven, when her coverage lapsed and the noise came back like a light switch—and she mistook a gap in her insurance plan for a moral failure.

She wasn’t confused.
She was reading the only explanation anyone had offered her, which was none.

What Changes When We Treat This as Data

When clinicians take this seriously—not as a footnote but as data—the prescription doesn’t change. Everything around it does.

It starts with a body composition scan, not just a weight, so muscle has a number attached to it before anything is lost—a number that can be defended later instead of guessed at.

It continues with a protein target that sounds almost aggressive, delivered on day one, because appetite has been flattened and eating on purpose now takes effort the drug was supposed to remove.

It includes a direct conversation about resistance training—not as an aesthetic add-on, but as the only intervention that tells the body which tissue to keep while the deficit runs.

And it means asking, before the drug ever starts, a question most intake forms don’t have a field for:

What has this noise been doing for you—and what do you expect to feel in the week it goes quiet?

Some patients answer immediately.
Some need a minute.
Either way, the answer belongs in the chart, not the margins.

It also means saying the uncomfortable part out loud at the first visit, not the eleventh: this drug is expensive, coverage is unstable, and if it lapses, the body does not gently return to baseline. It defends the weight it lost, and it defends it hard.

A plan for that month should exist before that month arrives—not be improvised inside it, in a patient’s private verdict that she is the one who failed.

The Plan Was the Problem

None of this is a cure. It isn’t even a protocol. It is a different way of looking at the same drug.

The prescription doesn’t change.
What surrounds it does.

She is back on the medication now, through a different channel. The forty pounds are coming off again—more slowly this time, with a protein target and a scale that measures more than weight.

Nothing about her chemistry changed between the first round and this one.

What changed was the question I asked before writing the prescription.

She was not the failure.
The plan was.

Follow a physician-led exploration of the hungers we don’t talk about—metabolic, emotional, and existential. Subscribe for clinical stories and tools that actually help

Subscribe now

More From Healing The Split: Life Beyond Labs Series

• Life Beyond Labs: What Your Doctor Missed (But Your Body Didn’t)

• Your Doctor Doesn’t Know What Your Grandmother Already Did

• The Ledger of Everything Unsaid

• A Body Scan for the Ones Who Live in Their Heads

• I’m an MD. Her Leaky Gut Wasn’t a Gut Problem — It Was a Life Problem.

Dr. Shiv Kumar Goel is a board-certified physician and writer specializing in Internal, Functional, and Aesthetic Medicine. As the founder of Prime Vitality Wellness in San Antonio, Texas, he practices a holistic, patient-centered approach that blends cutting-edge clinical medicine with ancient wisdom and integrative healing. His essays and op-eds have appeared in Doximity’s Op-Med, and he writes regularly on Substack (Healing the Split) and Medium.

Dr. Goel believes that medicine at its best is an act of recognition — helping patients return not just to health, but to themselves. He lives and practices in San Antonio, Texas.

All names and identifying information have been modified to protect patient privacy.

You have been told, “It’s life.”
“Stop overthinking.”
“It’s all in your head.”
“You’re just hormonal.”
“You’re fine.”

You try to believe it.

You go back to work. You keep the house moving. You push through the mornings that feel heavier than they should. You explain away the gut that turns unpredictable, the pain that moves, the sleep that breaks at 3 a.m., the edge in your mood that does not feel like you.

Then the part of you that has been quiet the longest speaks up.

You notice that the fatigue no longer responds to sleep. That the “just stress” headache has become a weekly appointment. That you are living inside a body you do not quite recognize, with symptoms you can list and a story you cannot quite tell.

So you do what you are supposed to do.

You see a doctor. You get the labs. You wait for the answer.

They come back normal.

“Everything looks good.”
“You’re fine.”

On the printout, this is good news. In your chest, it does not feel that way.

Because when your life has been quietly deteriorating, a normal result can sound less like reassurance and more like erasure. The numbers did not explain you. They seemed to erase you.

I am a board-certified internist. I have been practicing medicine for more than twenty years. I have ordered the panels that told patients they were “fine.” I have watched the small collapse in the face across from me when I said those words to someone whose body had been telling a different story for a long time.

I know what our current tools are designed to do. They are excellent at finding clear-cut disease — the tumor, the infarct, the infection, the crisis that must not be missed. They are not designed to detect what happens to a human body that has been living in prolonged stress, misalignment, or grief for years. That is not a failure of effort. It is a failure of frame.

That gap is what this essay is about.

For most of my career, I did what I was trained to do. I treated the fragment in front of me. The right medication. The correct referral. The appropriate workup. I was good at it. I was also, quietly missing something — the same thing I kept watching my patients miss, even when I handed them results that were technically reassuring.

The question that eventually changed my practice was not a clinical question.

It was this:

What if the body is not malfunctioning? What if it is escalating?

A whisper before it screams. A tightening of the jaw. A shift in sleep by thirty minutes. A gut that stops being predictable. A fatigue that is heavier than the day should have earned. A pain that migrates, returns, resolves, returns again.

We are trained to call this being stressed. Being anxious. Being too sensitive. Being a little run down.

What we are less trained to call it is what it often is:

A body telling the truth about a life that has stopped being heard.

A CBC cannot tell you whether your body has been bracing for twenty years.
A metabolic panel cannot tell you whether you learned in childhood that rest was dangerous.
A thyroid result cannot tell you whether your nervous system equates stillness with threat.
An inflammatory marker cannot always reveal the daily cost of swallowing grief, living in a relationship where your body never relaxes, or performing competence while slowly disappearing from yourself. verywellhealth+1

This does not mean those tests are useless.

It means they are incomplete.

The body is not divided into the same departments as the medical system. It does not separate cardiology from psychology, gastroenterology from grief, endocrinology from identity, immunology from loneliness, metabolism from meaning.

The body receives the whole life.

And it responds as one system.

This is not a rejection of medicine. It is an argument for asking more of it, not less.

The research already exists. Psychoneuroimmunology has mapped how chronic stress reshapes immune signaling. Circadian biology has shown that misaligned sleep timing keeps the body in a low-grade emergency even when total hours look adequate. The gut-immune axis has revealed how the microbiome influences inflammation, mood, and cognition. Trauma physiology has documented how early adverse experience resets the HPA axis decades later. The biology of meaning — purpose, connection, belonging — is now measurable in stress hormones, inflammatory markers, and health behavior adherence.

None of this is soft. All of it is biology.

The problem is not that the science is missing. The problem is that our clinical workflow still behaves as if a person’s marriage, grief, childhood adaptation, loneliness, work climate, and loss of purpose are separate from the panel.

They are not separate from the panel. They are what the panel is often silently measuring.

If you have ever driven home from a doctor’s appointment with a clean report and the quiet, disorienting sense that something has still been missed — you are not imagining it.

You may be living inside a pattern that has not yet been read.

That is not the same as being broken.

It is the beginning of a different question.

The labs can rule out many things. They cannot prove that a life is metabolizing safely inside a human body. That question — the one medicine has not yet built an instrument for — is worth asking.

The body is not random.

It is reporting.

And when medicine only measures the physical fragment, the whole pattern disappears.

This essay begins Life Beyond Labs: What Your Doctor Missed (But Your Body Didn’t) — a series for anyone who has ever walked out of an appointment with “normal” results and the quiet certainty that something important was still unread.

Dr. Shiv Kumar Goel is a board-certified internist and founder of Prime Vitality Care in San Antonio, Texas. He writes about the gap between normal lab results and persistent patient suffering. His forthcoming book is Healing the Split: When Your Biology Is Fighting Your Biography.

Everything I publish here stays free. That does not change.

But a few of you have asked how to support the work. So I turned that on.

You can now support the work as a paid or founding member. Nothing is locked behind it.

Here is what your support pays for. Time to write honestly. Cases rendered with care. A book, Healing the Split, being finished now.

Good labs. Bad life. There’s a reason. That sentence has found a lot of you. I want to keep chasing it.

If the work has meant something, you can back it below. If not, keep reading for free. Both are welcome.

Founding members get early chapters of the book, first access to what I build next, and my thanks by name.

Thank you for being here.

Shiv

There is a moment most of us know intimately, though we rarely name it. Someone asks something of us—our time, our agreement, our presence—and we say yes while everything inside us says no. The yes comes out smooth and warm. The no stays where it has always stayed: underground.

If you have been doing this work for any length of time, you have probably learned to call this a split. The performing self and the feeling self. The one who shows up and the one who got left behind. And somewhere along the way, you have likely absorbed the idea that this split is the problem. The defect. The thing to be eliminated.

I want to offer a different starting point, one grounded not in psychology, but in biology: the split was originally intelligent.

The Body’s Ledger

Think back to when the division first formed. For most of us, this is not a single dramatic moment but a slow accumulation of lessons. Anger made someone leave the room. Sadness made someone uncomfortable. The message arrived in a hundred small deliveries: some of you is welcome here, and some of you is not.

A child cannot survive that message by arguing with it. A child survives it by complying—by keeping the unwelcome parts out of sight.

And here is the thing we forget when we declare war on our own divisions: the adaptation worked. You are here. You made it through. The split that now frustrates you was once the most sophisticated protection available to a person who had very few options.

The split is not evidence of your brokenness. It is evidence of your ingenuity under conditions you did not choose. But the body keeps the ledger of everything unsaid. The adaptation does not stay in the mind; it writes itself into the tissue.

Why Demolition Fails

This matters practically, not just philosophically, because the stance we take toward the split determines whether healing is possible at all.

When we treat the split as an enemy, we approach it the way we approach any enemy: with force, with judgment, with the intention to destroy. We try to make ourselves authentic—a contradiction so complete that the effort defeats itself.

The nervous system registers this effort exactly as it has always registered a threat. It tightens. The physiological state of sustained defense remains active. You cannot bully a nervous system into standing down. You can only convince it that the danger has passed.

Renegotiation, Not Removal

What actually changes things—slowly, undramatically, the way real change moves—is approaching the split from a third position: gratitude for the protection, honesty about the cost.

Not gratitude as performance. Not “thank you, now please leave.” Something closer to the gratitude you might feel toward a biological system that has been running a stress response for thirty years because no one ever told it the war ended. There is respect in that recognition. There is grief in it too—for how long the post was held, and for what the holding cost in fatigue, in inflammation, in a life lived at a fraction of its capacity.

From that stance, a different kind of conversation becomes possible. Instead of why are you malfunctioning, we can ask: what were you protecting me from?

The nervous system does not surrender to this conversation; it softens into it. The split does not vanish. It becomes permeable. The no that lived underground starts to surface in small, survivable ways: a pause before the automatic yes, a sentence spoken slightly closer to the truth, a physical sensation allowed to stay in the room thirty seconds longer than it used to.

This is what integration actually looks like from the inside. Not a wall coming down in one cinematic moment, but a physiological shift from defense to safety.

A Question to Sit With

So today, instead of asking how do I get rid of my split, try asking the older, kinder question:

What was this division protecting, and what did the protection cost?

Both halves of that question matter. The first honors the biological intelligence of the adaptation. The second honors your right to want something more than survival now.

The split is not your enemy. It was your biology loyally following your biography.

Subscribe to Healing the Split
Join a community exploring the space where modern medicine ends and the rest of the body’s intelligence begins. Free weekly essays on the physiological cost of the lives we survive, and the science of coming home.

Subscribe now

About the Author
Dr. Shiv Kumar Goel, MD, FACP, is a board-certified internal medicine and functional medicine physician practicing in San Antonio, Texas. He is the founder of Prime Vitality Care and the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography.

You cannot think your way out of a body you’ve been ignoring for years. I know, because I tried for most of my adult life.

If you live almost entirely in your mind — analyzing, planning, narrating — this will feel foreign at first. Good. That’s the point.

We’re not trying to add another thought.

We’re trying to come home to the thing that has been carrying you this whole time.

The practice

Five minutes. No app required.

1. Arrive — 30 seconds. Sit or lie down. Let your eyes close, or soften your gaze toward the floor. Take one breath that’s slightly longer on the exhale than the inhale. You’re not relaxing yet. You’re signaling to your nervous system that it’s allowed to.

2. Feet and legs — 1 minute. Bring attention to the soles of your feet. Not the idea of your feet — the actual sensation. Warmth, pressure, tingling, nothing at all. Whatever is there is correct. Move slowly up through your ankles, calves, knees, thighs.

3. Center — 1.5 minutes. Move into your pelvis, your belly, your lower back. This is where a guarded body holds its oldest tension. Don’t try to release anything. Attention landing on a place the body has been bracing is itself a signal that the bracing is no longer required. The noticing is the medicine.

4. Chest, shoulders, hands — 1 minute. Let your attention rise to your chest. Is the breath shallow or full? Travel out across your shoulders. The shoulders are the great storage shelf of the overthinker. Move down the arms, into the palms.

5. Head and whole body — 1 minute. Soften the jaw, the eyes, the space between the brows. Then, for the last stretch, hold your entire body in awareness at once. One field of sensation. Breathing. Alive. Yours.

Why this matters more than it looks

There’s a reason I anchor this in the body and not the mind. Your physiology runs on rhythm — circadian, ultradian, the daily tides of cortisol and rest. When you live only in your head, you override those signals constantly. Over time, that override compounds: the HPA axis stays primed, inflammatory tone rises, and sleep architecture quietly degrades — not because anything is broken, but because the body stopped receiving permission to stand down.

A body scan is a small act of re-syncing. A moment where you stop directing the body and start listening to it.

Do it once. Notice what comes up. That’s all.

The body keeps better records than the mind.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com. His work appears in KevinMD, Op-Med, Medium, Elephant Journal, and San Antonio Medicine.

Irene came in for migraines.

That was the chief complaint. Thirty-six years old, elementary school teacher, already diagnosed with irritable bowel syndrome, already scoped twice — endoscopy and colonoscopy both showing diffuse inflammation, gastritis, GERD. Already told she couldn’t tolerate GLP-1 medications because of her IBS. She had done her research online and found me.

She seemed, on the surface, like a patient with a well-documented GI history and a headache problem.

I almost missed what was actually going on.

She mentioned she wanted to lose six pounds. I looked at her. She was in good shape. Six pounds was not a medical problem. I asked why.

She said she wanted to stay young and pretty as she got older.

I asked what her weight had been two years ago. She said she had been about ten pounds lighter. They had just gotten married around that time. She smiled when she said it — he was crazy about me.

Is he not crazy about you now?

I made it light. She half-laughed. Then she said: yeah, it’s just…

And she stopped.

I asked about sleep. She said it had never been great but had gotten significantly worse over the last year or so. I asked what changed. She said nothing. Her husband worked construction, came home late, slept like a baby. I said: well, someone in the house is getting good sleep.

She didn’t laugh that time.

The picture was assembling itself. Poor sleep for over a year. Weight gain of ten pounds. IBS worsening. Migraines. Irregular periods for the past few months — she was worried about early menopause, and they hadn’t had children yet. A marriage that had quietly shifted into something she didn’t have words for yet.

She wasn’t imagining any of it. She was not broken. Her body was doing exactly what a body does when it is living inside a chronic stress load it cannot name and cannot escape.

What “Leaky” Actually Means

Before I tell you what her tests showed, it is worth pausing on the biology. Because “leaky gut” is one of those terms that has been simultaneously dismissed by mainstream medicine and overclaimed by the wellness economy — and both camps have gotten it partly wrong.

The gut epithelium is a single cell layer thick. One cell. Separating the lumenal contents — bacteria, food antigens, endotoxins — from the portal circulation and the systemic immune system. That architecture should be astonishing every time we consider it.

What holds it together is a network of tight junction proteins: occludin, claudin, ZO-1, ZO-2. These proteins form a dynamic seal between adjacent epithelial cells. They are not static. They open and close in response to bacterial metabolites, dietary composition, cortisol, alcohol, NSAIDs, and inflammatory cytokines.

Cortisol is particularly relevant here. Chronic HPA axis activation — the kind produced not by a single stressful event but by sustained, low-grade, inescapable pressure — directly downregulates tight junction protein expression. The barrier does not fail suddenly. It is quietly dismantled, over months, by the body’s own stress response.

Intestinal hyperpermeability — the clinical term for what the wellness world calls leaky gut — is what happens when that dismantling goes unchecked. Bacterial lipopolysaccharide (LPS), food-derived antigens, and microbial metabolites that should remain in the lumen cross into the lamina propria and portal circulation. The immune system encounters them. It responds. That response is not localized. It is systemic. And it is measurable.

This is not fringe biology. Dr. Alessio Fasano’s foundational work at the University of Maryland established zonulin as the primary endogenous regulator of tight junction permeability. Elevated serum zonulin is a measurable, reproducible marker of barrier dysregulation. It has reference ranges. It gives the clinician something to act on — not a diagnosis to argue about, but a number that either confirms the clinical picture or complicates it.

The argument about whether leaky gut is “real” is the wrong argument. The tight junctions are real. The permeability is measurable. The downstream immune activation is well-characterized. What has been legitimately debated is the overclaiming — the wellness industry’s habit of attributing everything from autism to autoimmune disease to a leaky gut without measuring any of it.

Both positions miss the patient sitting across from you.

The Tests That Make the Picture Precise

Irene’s tests confirmed what her story had already told me.

Cortisol was persistently elevated — not a single high morning reading but a pattern of dysregulation across the diurnal curve. The morning awakening response was blunted. The evening cortisol was elevated when it should have been low. Her HPA axis was running hot and running late.

Her gut permeability panel showed serum zonulin elevated above the reference range. LPS antibodies — IgG and IgA fractions — were positive, indicating active LPS translocation across the barrier into systemic circulation. Secretory IgA was low, meaning her mucosal immune defense, the first-line antibody that should be patrolling the gut lumen, was depleted. Fecal calprotectin confirmed active intestinal inflammation — a neutrophil-derived marker that the colonoscopy had characterized structurally but not etiologically. A GI-MAP identified dysbiotic gram-negative bacterial overgrowth. Gram-negative bacteria are the primary LPS source. The bacteria were producing the endotoxin. The endotoxin was crossing the barrier. The barrier was failing because the cortisol had been taking it apart for eighteen months.

The GI physician had scoped her and found inflammation. That was accurate. What the scope cannot show is why the barrier is failing. It cannot measure zonulin. It cannot quantify LPS translocation. It cannot tell you that the tight junction proteins holding that single-cell layer together have been chemically dismantled by sustained cortisol exposure.

A complete panel for intestinal permeability includes: serum zonulin, LPS antibodies (IgG, IgM, IgA), secretory IgA, fecal calprotectin, and a comprehensive stool analysis such as GI-MAP. These tests are available. They have reference ranges. They are not experimental. They change what you treat and in what order.

Test, don’t guess. This is the line that separates functional medicine from functional guessing.

The Root Cause Was Never the Gut

Here is what I want to say clearly, because it is the part that gets lost in the supplement protocol.

Irene’s root cause was not leaky gut.

Leaky gut was where we found the damage. The root cause was a 36-year-old woman trying to hold a marriage together in silence, wanting a child, teaching other people’s children every day while quietly grieving the version of herself her husband used to reach for. The ten pounds on the scale were not a metabolic problem. They were a measurement of something she had no language for yet.

The cortisol was not a lab abnormality. It was the biochemical signature of a life being carried alone.

The barrier failure, the dysbiosis, the irregular cycles, the migraines — these were downstream. They were faithful. The body was not malfunctioning. It was escalating. It was writing in every available medium — gut, hormones, sleep, cycle, head pain — the story that Irene had not yet been able to speak out loud.

This is the part that neither mainstream gastroenterology nor the wellness economy is equipped to hold. The GI physician cannot spend forty minutes in that room. The supplement company cannot ask about the marriage. The algorithm cannot hear the pause after yeah, it’s just…

But the clinician can. That is still, despite everything, what we are for.

Your symptoms are not random. They are your biography written in your biology.

The Repair Protocol — Sequenced, Not Scattered

When the biology is this layered, the repair protocol must be sequenced. Treating the gut without addressing the HPA axis is like mopping the floor without turning off the tap.

First: the cortisol. You cannot repair a barrier that is being continuously degraded by its own stress hormones. For Irene, this meant addressing sleep directly — circadian rhythm anchoring, consistent sleep and wake times, reducing evening cortisol through light management and nervous system support. It meant creating space for the conversation about her marriage that she wasn’t ready to have yet — not forcing it, but opening the door. Adaptogenic support for HPA axis regulation: ashwagandha, phosphatidylserine, rhodiola in appropriate combination. Her irregular cycles were not a separate problem. Chronic cortisol elevation suppresses pulsatile LH release. The HPA axis and the HPG axis share regulatory circuitry. When one is dysregulated, the other follows. The gut problem and the cycle problem and the sleep problem were one problem in three departments.

Second: the barrier substrate. L-glutamine at therapeutic dose — the primary fuel source for enterocytes, the cells that line the gut wall, depleted in states of chronic intestinal stress. Zinc carnosine specifically for tight junction integrity, studied in NSAID-induced gut injury and chemotherapy-associated mucositis, with dual mechanisms through both zinc’s role in tight junction protein synthesis and carnosine’s direct mucosal protection. Saccharomyces boulardii CNCM I-745 — not a generic probiotic, but a specific non-colonizing yeast with documented effects on sIgA upregulation, pathogen exclusion, and tight junction support. Sodium butyrate for colonocyte fuel and tight junction gene expression via histone deacetylase inhibition. Deglycyrrhizinated licorice for the gastric mucosal layer, given her GERD and active gastritis findings.

Third: the microbial environment. The gram-negative dysbiosis driving her LPS load required a targeted approach — not a broad-spectrum antimicrobial, but a combination of specific herbal antimicrobials guided by the GI-MAP sensitivities, followed by a structured reseeding protocol. Fiber diversity to support butyrate-producing commensals. Fermented foods when tolerated.

Fourth: the anti-inflammatory dietary framework. Not a 30-day elimination protocol. The wellness economy sells 30-day cycles because 30 days is marketable. Real barrier remodeling takes three to six months minimum. Biology has its own clock. The goal is not a perfect elimination diet that creates new anxiety around food. The goal is a sustainable reduction in inflammatory dietary load — processed seed oils, refined carbohydrates, alcohol — while preserving the pleasure and the cultural and relational meaning of eating. Food eaten in fear does not heal a gut.

The Systems View — Where This Goes If You Miss It

Irene’s case is not unusual. It is typical of what goes undiagnosed when we treat organ systems as separate.

The gut-HPA axis is bidirectional. Chronic intestinal inflammation drives cortisol dysregulation through cytokine-mediated HPA activation. Chronic cortisol elevation, in turn, directly disrupts tight junction integrity. The downstream effect — increased LPS translocation — activates NF-κB signaling and systemic inflammatory load. The cycle feeds itself.

The gut-brain axis runs through the vagus nerve, through microbial metabolite production — short-chain fatty acids, tryptophan metabolites, GABA precursors — and through enteric nervous system cross-talk. The LPS translocation Irene had was activating neuroinflammatory pathways that were contributing to her migraines. Her head pain was not separate from her gut. It was downstream of it.

The gut-cycle axis is less discussed but clinically significant. The estrobolome — the collection of gut bacteria responsible for estrogen metabolism — was disrupted by her dysbiosis. Estrogen recirculation was impaired. Combined with HPA suppression of LH pulsatility, her cycle had no stable hormonal environment to work within.

The gut-skin axis will present in her future if the barrier is not repaired. LPS translocation drives systemic mast cell activation. Mast cell activation has dermal expression — acne, rosacea, eczema, unexplained urticaria. The patients who treat their gut and notice their skin improving are not imagining things. The connection is real even when it is invisible to specialists managing each organ system separately.

This is what the siloed model of medicine cannot hold. Not because the specialists are wrong within their domain. But because the patient does not live in a domain. She lives in a body. And the body is one connected system, following one set of rules, telling one story — in every language it has available.

What Happened to Irene

Three months later, her migraines had decreased significantly in frequency. Her periods had regularized. She had lost the six pounds — not because we targeted the weight, but because we addressed the cortisol-driven visceral fat accumulation upstream of it. Her sleep was better. Her zonulin had come down. Her sIgA had recovered. The LPS antibody titers were trending toward resolution.

She came in for a follow-up and said something I have heard versions of many times: I didn’t realize how bad I felt until I started feeling better.

I asked about the marriage. She smiled differently than she had the first time. Still complicated. Still in progress. But she had started saying things out loud that had been living in her body for a year and a half.

The gut was not her problem. The gut was where her biography had started writing itself in biology.

To the physician reading this: Irene’s root cause was not leaky gut. Leaky gut was where we found the damage. The root cause was a 36-year-old woman trying to hold a marriage together in silence, wanting a child, not sleeping, and watching ten pounds on a scale represent something her husband used to see that she was afraid he no longer did. The cortisol was not a lab abnormality. It was the biochemical signature of a life being carried alone. The barrier failure, the dysbiosis, the irregular cycles — these were downstream. They were faithful. The body doesn’t malfunction. It escalates. If you have patients like Irene — scoped, diagnosed, medicated, still symptomatic — the upstream layer is worth mapping. Zonulin, LPS antibodies, diurnal cortisol, sIgA. These are not esoteric tests. They are available, they have reference ranges, and they change the clinical picture.

To the patient reading this: if your tests are back and the treatments aren’t working, ask the harder question. Not what is wrong with your gut. Ask what your gut is responding to. The answer is almost never in the colon. It is almost always upstream — in the life the body has been asked to carry.

You are not imagining it. You are not broken. The map your physician has may simply be missing a layer.

Ask for the layer.

Good labs. Bad life. There’s a reason.

You cannot heal what you don’t measure. But you also cannot measure your way to the right question without first listening to what the patient is actually saying.

Irene told me everything in the first ten minutes. I just had to stop charting long enough to hear it.

All identifying details modified. Composite elements used to protect patient privacy.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com.

During my anesthesia residency in Delhi, I read a description I still can’t shake.

Before modern anesthesia, surgery meant enduring it. Herbs, alcohol, cold, compression, intoxication—anything to blunt consciousness enough to cut. Some patients died from the attempt before the procedure even began. And many survived the anesthetic only to face the knife fully awake.

That wasn’t a rare historical horror. It was the ordinary condition of being sick in a body that needed to be opened.

For twenty years, that image has followed me. Not as a clinical curiosity, but as a reminder of how thin the membrane is between what medicine can do now and what it couldn’t do just a few generations ago. We crossed that line recently enough that the memory still echoes.

The First Healers

Long before the white coat, there was the medicine woman.

She was the midwife, the herbalist, the watcher of fevers, the keeper of remedies. Healing wasn’t divided into departments. Birth, grief, fertility, pain, sleep, community—these lived in the same circle of care. Illness was never separated from the life surrounding it: the family, the season, the fear, the loss.

We know some of their names. Peseshet, in Egypt’s Old Kingdom, nearly 4,500 years ago, held a title that translates to “overseer of female physicians.” She didn’t just practice medicine; she supervised other women who did.

Agnodice of Athens—whether historical or partly myth—was said to have disguised herself as a man to practice medicine because women weren’t permitted to. The story is symbolic of something that was true almost everywhere: women stood at the center of healing while being systematically kept outside its institutions.

Their medicine had limits. It was entangled with superstition, and it could not defend against the infections, cancers, or cardiac events we now routinely treat. People died of conditions we would catch on a Tuesday afternoon.

But their medicine also held something ours has largely misplaced: the understanding that illness was never only biological. It was emotional, familial, spiritual, environmental. The sick body lived inside a life, and the life was part of the diagnosis.

The Great Acceleration

Then medicine sped up—and it has never slowed down.

In 1847, Semmelweis showed that handwashing cut maternal deaths by more than 80%. His colleagues rejected him.

A few decades later, Lister brought Pasteur’s germ theory into the operating room, and antisepsis changed what surgery could survive.

In 1928, Fleming noticed penicillin growing in a petri dish he’d forgotten to clean. By the 1940s, a bacterial infection had gone from a likely death sentence to a ten‑day prescription.

Vaccines, transplant medicine, the ICU, imaging, genomics, robotic surgery, the sensor on your wrist—this is arguably the most compressed run of technical advancement in the history of any profession.

We bought years with it. Life expectancy in the U.S. was around 47 in 1900. By 2019, it was past 78.

The anesthesia bay where I trained—continuous oxygen monitoring, end‑tidal CO₂, real‑time depth‑of‑sedation tracking—would have looked like science fiction to surgeons working before the first public ether demonstration in 1846.

That is a civilization‑scale shift in less than a human lifespan.

What the Acceleration Cost

Every transformation sends a bill.

As medicine grew more powerful, the room where it happened grew smaller. Faster. More instrument‑dependent. The average physician visit in the U.S. now runs about 18 minutes.

The family that shaped the illness. The community that held the patient. The childhood buried in the history.

None of that fits neatly into a note. It isn’t coded. It isn’t reimbursed. So the encounter was built around what could be measured—and quietly stopped being built to hold the rest.

The result is a patient every clinician recognizes: thoroughly worked up, composed, and still somehow getting worse. Labs normal. Scans clean. And underneath it all, a body running on chronic stress hormones, a circadian rhythm that never resets, a nervous system on alert since childhood—none of which shows up on a standard panel, even though the biology is now well documented.

Nobody decided to remove presence from medicine. We optimized for speed, throughput, measurable outcomes. Presence was simply what got left on the floor.

The AI Physician, and the Question Beneath It

Now medicine is accelerating again.

AI systems can read a retinal photograph and catch diabetic retinopathy with ophthalmologist‑level accuracy. They can detect the early shape of sepsis in vital signs before a patient meets a single official criterion. They can flag readmission risk or medication gaps at a scale no human could match.

This isn’t speculative. It’s already running in radiology departments, ERs, and chronic disease programs—including several here in San Antonio.

So the real question was never whether AI belongs in medicine. It does. The diagnostic power is real, and the lives it will save are real.

The question is what remains for the human sitting across from the patient—the part the algorithm cannot touch.

The algorithm will find the abnormal value. It will not know the fatigue is grief. It will not connect the insomnia to the marriage. It will not notice the chest pain began the week the patient’s father died. It cannot ask, When did your body first stop feeling safe? And it cannot hold the silence afterward.

The physician of the next twenty years will need to be bilingual: fluent in the data, and fluent in the human being producing it. Not one instead of the other. Both, in the same fifteen minutes.

What the History Is Trying to Tell Us

I don’t see the arc from medicine woman to AI physician as a straight line of progress. It’s a pattern that keeps repeating: every leap in technical power carries the same hidden risk—that the instrument becomes the whole inquiry.

Germ theory freed medicine from superstition and gave us the pathogen. It also made it easier to ignore the terrain the pathogen landed in.

The randomized controlled trial gave us evidence‑based medicine. It also cost us the individual patient who never looked like the trial population.

The diagnostic panel gave us the abnormality. It also cost us, far too often, the story.

AI is simply the next version of that same bargain—and, if we’re paying attention, the next chance not to make the same trade.

Here in San Antonio, the history of medicine isn’t only technological. It’s a history of healers—physicians, nurses, community health workers, promotoras, curanderas—who carried presence alongside knowledge. The curandera tradition is, in a real sense, an unbroken thread back to the earliest healers: holistic, embedded in community, attentive to body, emotion, and spirit at once.

That combination—presence and knowledge, story and data—isn’t a relic. It’s the standard our profession has quietly aspired to all along, even in the decades our own structures made it hard to reach.

The oldest medicine knew something the newest medicine is relearning.

A sick body lives inside a story. And the story is always part of the diagnosis.

A longer, footnoted version of this piece appears in this month’s San Antonio Medicine.

Read more from Healing the Split

If this piece touched something your body already knew, you may find resonance in these other stories from the archive. Each one sits where medicine, memory, biography, and healing overlap.

• The Body Remembers What the Mind Was Never Told — on what the body carries before language, diagnoses, or lab ranges catch up.

• Good Labs, Bad Life — when the chart says “normal” but the lived experience does not.

• The Unsent Sentence — the words your nervous system has been saying for years that never made it into a medical note.

• The Three-Generation Contract — how illness and healing often begin long before your own birth and continue long after your own labs.

  ---

Dr. Shiv Kumar Goel is a board‑certified internist practicing functional and integrative medicine in San Antonio, Texas, through Prime Vitality Care. He is writing Healing the Split: When Your Biology Is Fighting Your Biography.

I am just a train wreck.

I asked him why he said that.

Stefan was fifty-six. A financial consultant. He had been carrying a diagnosis of autoimmune neuropathy for eight years. The workup had been thorough. MRI. CT. EMG. EEG. CSF studies. A hospitalization. An ICU stay. IVIG that nearly killed him before it helped. He had survived all of it. He was in front of me anyway, still falling sometimes, still tired in a way sleep did not touch.

I ran the autoimmune and neuromuscular panels again. All negative. His morning cortisol was low. His four-point curve was nearly flat. His testosterone was low for his age, but not surprising. Everything else looked acceptable on paper.

I asked him what his life had looked like in the year before the first fall.

He told me. A divorce. A car accident a few months earlier. Travel through six states for work. A legal case. His father, slowly going under to dementia, with a long history of his own — a divorce, alcohol, the slow exit from working life. Stefan’s parents had divorced when he was twelve. He had moved often as a child. His great-grandparents had left Germany. He did not know when. No one in the family did.

Stefan’s body had been answering a question it was never asked.

For decades, medicine assumed that what happened to your grandmother stayed with your grandmother. Her grief was hers. Her terror was hers. Her flight from one country to another was hers. The biology, we believed, started fresh in each generation.

That assumption is no longer holding.

In 2025, a Yale-led team studied three generations of Syrian families displaced by war. They found twenty-one DNA methylation sites that mapped to direct exposure to violence. They found fourteen sites that appeared in grandchildren who had never seen the war. Thirty-two sites carried a common epigenetic signature across all three generations. The grandchildren had been born in safety. Their genomes had been reading a different story.

Rachel Yehuda’s work on FKBP5 had laid the ground for this finding more than a decade earlier. FKBP5 is one of the genes the body uses to learn how to answer threat. Once it learns, it can pass the answer forward.

NR3C1 and BDNF show the same pattern across trauma cohorts. The genes that govern how a body braces, how it sleeps, how it grows, how it grieves — they keep what they have been taught.

This is not metaphor. It is methylation.

Every tradition I have read named some version of this long before the methylation studies arrived.

In Sanskrit, the word is samskara. It refers to the impressions left on a life by what came before — actions, encounters, sorrows, devotions — carried not as memory but as orientation. The body inherits a posture toward the world. The mind catches up later, if it catches up at all.

I grew up around the word. I did not understand it until I started seeing patients like Stefan.

The body was the first archive. The genome is the second.

The science is real. It is also early.

We do not yet know which marks survive the epigenetic erasure that normally precedes birth. We do not yet know whether prenatal exposure and germline exposure leave the same kind of inheritance, or two different kinds. We do not yet know whether the same marks that pass forward vulnerability also pass forward resilience — whether the body that learned to brace also learned to soften. We do not yet know whether the chain can be deliberately interrupted, and what deliberately would mean at the molecular level.

I am a physician. I want the answers. I do not yet have them. Neither does the field.

That is the honest sentence.

I told Stefan some of this. Not all of it. He did not need a lecture. He needed a different question.

I asked him to tell me about his grandfather. He laughed a little, because no one had asked him that in a clinic before. Then he told me. The grandfather had farmed until eighty-two. Came home from the field one evening and was gone in a moment. The father had moved often for work. After the divorce, he had stopped working and started drinking. Stefan had moved with him as a boy. He had learned early that if he stopped moving, no one would come for him.

He had been moving ever since.

He stopped apologizing for the fatigue. He stopped apologizing for the falls. He was quiet for a long time, and then he said, so my body has been doing this on purpose.

I told him his body had not been doing anything on purpose. His body had been doing what it had been trained to do, by men he had loved, by men they had loved, going back further than anyone in his family could now remember.

His neuropathy did not lift that afternoon. That is not how this works. But something else did.

I know the pattern in Stefan because I have lived a version of it.

I have carried, all my life, a fear that I am not enough. That no matter how much I do, I will have to keep doing, because there will not be anyone for me if I stop. So I did more than I was asked, for everyone, all the time. I told myself it was generosity. It was partly that. It was also a calibration.

My father carried it before me. He gave his salary to his parents and his ten younger siblings. He gave the recreational funds meant for our family of seven. He played the good son, the good brother, the good father, until it crushed him. His own father — my grandfather — farmed in the field until he was eighty-two. Came home one evening. Was gone in a moment. My great-great-grandfather left what is now Pakistan. No one in our family knows the year. No one knows the reason.

Four generations of the same shape. Different fields. Different soils. Same posture.

Good labs. Bad life. There’s a reason.

I fell and fell but never failed.

If your body has been carrying something it never agreed to carry, what does it mean to be the first one to set it down?

You will not set it down by trying harder. You will not set it down by optimizing. You will not set it down by knowing the science of FKBP5 or by reading one more paper on methylation, including this one.

You will set it down by turning toward the body you have, the lineage you came from, and the silences none of them ever broke. You will set it down by asking the question no one has asked you in a clinic before.

Hi friend, can I meet you again?

Stefan is a composite. Identifying details have been altered. The clinical pattern is real.

Sources

• Mulligan, C. J. et al., on epigenetic signatures of intergenerational exposure to violence in Syrian refugee families. (Mulligan et al., 2025)

• Yehuda, R. et al., on FKBP5 methylation and intergenerational transmission of stress response. (Yehuda et al., on FKBP5)

• Review of multi-generational trauma epigenetics across cohorts (FKBP5, NR3C1, BDNF). (Epigenetic changes associated with multi-generational trauma, 2026 review)

Dr. Shiv Kumar Goel is a board-certified physician in Internal, Functional, and Aesthetic Medicine and the founder of Prime Vitality Care in San Antonio, Texas. With over twenty years of clinical experience, his work weaves evidence-based medicine with circadian biology, trauma-informed care, and the deeper questions beneath the symptoms. He writes at the intersection of medicine, memory, and meaning, and is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography. Read more at healingthesplit.com.

After I published “Good Labs, Bad Life,” my inbox filled with a different kind of question. Not just What do I do next? — but How do I live with myself when the people in white coats keep telling me I’m fine? You were not just asking for a second opinion. You were asking how to trust your own body again when the system keeps shrugging.

So this time, instead of starting with the labs, I’m starting with you: the person who feels something is wrong but walks out of appointments feeling overdramatic, broken, or invisible.

Q1. Why does my doctor say I’m fine when I clearly don’t feel fine?

Most physicians are not trying to gaslight you. They are trying to answer a narrow question with the tools they’ve been given: Is there an immediate, measurable danger that I can see on these tests? If your basic labs, imaging, and exam don’t show that danger, the safest thing they know how to say inside that system is, “Everything looks good.”

But “no emergency” is not the same as “no problem.” Standard panels were designed to catch disease late and obvious, not early and subtle. So you end up living in the gap: too sick to feel like yourself, not sick enough to trigger the alarm bells they were trained to listen for.

Q2. If the tests are normal, is it all just in my head?

No. It is in your nervous system, your hormones, your sleep, your history, your timing, your relationships, and your physiology — which includes the brain and the stories it has had to tell to keep you alive. In medicine we often split bodies from minds because the systems are built that way: one code for depression, another for joint pain, another for IBS, and no code at all for “My life fell apart three years ago and my body has been talking ever since.”

In clinic, I have learned this: when a patient says, “Something is wrong,” they are almost always right. The question is not whether something is wrong, but where we are willing to look. If we only look at static lab ranges designed for late‑stage disease, we will miss the slow, lived breakdown long before the numbers catch up.

Q3. Why does every appointment feel rushed and dismissive?

Most modern visits are designed around efficiency, not listening. Ten to fifteen minutes to review your chart, click through a checklist, refill medications, and document everything in an electronic record that was built for billing more than it was built for healing. That time pressure shapes the conversation: your story has to fit into the small spaces between the boxes.

Under that pressure, it’s much easier to say, “Your tests look good, maybe it’s stress,” than to say, “I believe you. Something is off. We may need more time and a different approach.” The system rewards doctors who move quickly through problems. It does not reward the ones who sit with mysteries.

Q4. What might medicine be missing when it says “Everything looks good”?

Quite a lot. Here are three big categories I see over and over again:

• Early dysfunction instead of obvious disease. Blood sugar, thyroid, inflammation, and hormones can all be technically in range while already drifting in the wrong direction for your particular body.

• The impact of trauma, chronic stress, and unprocessed loss. Your nervous system can spend decades in fight‑or‑flight or freeze, keeping you functional on the outside while quietly wearing down your heart, immune system, gut, and sleep architecture.

• Timing and circadian rhythm. Lab snapshots at 8 a.m. do not show how your cortisol, blood pressure, mood, or heart rate variability collapse at 2 p.m. or 2 a.m. The body is a 24‑hour conversation; most panels give us a single word.

When we widen the lens to include these, “Everything looks good” often turns into “No wonder you feel the way you do.”

Q5. How do I advocate for myself without feeling like a “difficult” patient?

You don’t have to become combative to be clear. A few phrases I’ve seen change the temperature in the room:

• “I hear that the tests look okay. Can you help me understand what else could be causing these symptoms?”

• “My biggest fear is that nothing will change and I’ll still feel this way in a year. What would you do if this were your body?”

• “If this were your sister or partner, what next steps would you want them to take?”

These questions invite your doctor into partnership instead of defense. If you repeatedly get the sense that your lived experience is being minimized, it is not overreacting to look for another clinician — someone whose training or temperament allows more space for the kind of complexity you live with.

Q6. When should I consider a different kind of care, like functional or integrative medicine?

You don’t have to choose between conventional and functional medicine. The best care often uses both. If you have:

• Normal basic workups

• Persistent symptoms that are disrupting your ability to work, connect, or rest

• A sense that your body is “off” in a way no one is tracking

— then a physician who can spend more time, run more targeted labs when appropriate, and actually map your timeline (when symptoms started, what was happening in your life, how your rhythms shifted) can be helpful.

This is where I work most often: at the intersection of standard testing and the lived story, using both physiology and the mind–body connection to understand why your system is reacting the way it is.

Q7. What can I start doing now, even before I find the “right” doctor?

While you look for someone who will take you seriously, you can begin to collect the kind of data that actually matters:

• A simple symptom and energy journal. Note sleep times, wake times, energy peaks and crashes, pain flares, mood shifts, and major stressors for at least two weeks.

• Meals and movement. Not to count calories, but to notice patterns: what you ate before that 3 p.m. crash, or how your body feels on the days you walk versus the days you don’t.

• Nervous system check‑ins. Even 5–10 minutes of daily breathing, meditation, or somatic work begins to change the “weather” inside your body. Think of it as giving your system a chance to unclench so we can see what’s left when the emergency sirens quiet down.

None of this replaces proper medical care. But it does something equally important: it anchors you back inside your own experience, instead of leaving you dependent on a single set of numbers taken once a year.

Q8. How do I stay hopeful when I feel dismissed again and again?

One of the hardest parts of being told “You’re fine” is the loneliness. You start to question not just your body, but your sanity, your memory, your worthiness of care. I wish I could sit in the room with you and say this out loud: Your symptoms are real. Your experience is valid. The fact that the system doesn’t have an easy label for you does not make you imaginary.

If life has split into a “before” and “after” — before the fatigue, before the pain, before the fog — then your work now is not to pretend nothing has changed. It is to let this version of you have a voice, and to keep looking until you find people and practitioners who can hear it. You were never meant to do this alone.

If you read this and heard your own story between the lines, you’re who I wrote it for. In the next Q&A, I’ll move from these broad questions into specific patterns I see over and over again — hormones, gut, sleep, trauma, and timing — and how we can start to unwind them without turning your life into a full‑time job.

If there’s a question you want me to hold in that next piece, you can reply to this email with a few lines about what you’re carrying right now.

Details changed and composited to protect privacy. The truth of it is intact.

She spoke for forty minutes straight. I never said a word. That was the day something shifted — not for her, at first, but for me.

She had come in with three things: fatigue that no amount of sleep touched, a mind that wouldn’t stop running, and a stomach that clenched without reason. Her workup was unremarkable. And from the moment she sat down, she talked. Rapidly, brilliantly, without a single pause long enough for me to enter. She narrated her symptoms, her theories, her schedule, her childhood, her last three doctors.

A performance of total disclosure that somehow disclosed nothing.

For weeks I had tried to redirect her. I asked targeted questions. I interrupted, gently. I tried to move her toward the data I thought I needed. None of it worked. She absorbed every intervention and kept talking, the way water moves around a stone.

That day I tried something else. I simply stopped trying to get in. I let the silence she was so afraid of sit in the room between us. And I watched what she did to keep it from arriving.

What the talking was for

Here is what I came to understand. Her language was not communication. It was armor. As long as she was speaking, she could not feel. The flood of words was a wall she rebuilt, sentence by sentence, against something underneath that she was certain would overwhelm her if it ever reached the surface.

This is the part medicine rarely teaches: a symptom can be a strategy. The racing mind was not random noise to be sedated. It was doing a job. It was protecting her from a grief she had never let herself carry.

The turn

When she finally ran out of words, she went quiet. And in that quiet, for the first time, her eyes filled. She said, almost surprised: “I haven’t stopped talking since my mother died.”

Three years. Three years of filling every silence so the silence couldn’t fill her.

And people always do run out of words — if you can tolerate not rescuing them from it. That is the whole skill. Not technique. Tolerance.

We did not fix anything in that visit. But we found the door. The body scan, the breath work, the slow rebuilding of her tolerance for stillness — those came later. And they worked, because we had finally named what the talking was for.

The lesson I keep relearning

The most important thing I bring into a room is the willingness to stop filling the silence myself. Sometimes the clearest signal a patient gives is the thing they are working hardest not to say.

The body keeps that score too. Not just the grief. The effort of keeping the grief buried.

These are the stories that taught me how to actually listen. If this one found you, the next one will be in your inbox.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com. His work appears in KevinMD, Op-Med, Medium, Elephant Journal, and San Antonio Medicine.

She had seen five physicians in two years. Every panel came back clean. She sat across from me holding a folder of normal results and said, quietly: I feel like I’m disappearing.

I have signed off on thousands of lab panels. Comprehensive metabolic profiles. Thyroid cascades. Inflammatory markers, hormone panels, the whole alphabet of modern diagnostics. And I have watched a particular kind of patient sit across from me, holding results that say, in the cold language of reference ranges, that they are fine.

They are not fine.

The gap nobody charts

There is a gap in medicine so wide and so common that we have stopped seeing it. It is the space between measurable biology and lived experience.

On one side: your bloodwork, your imaging, your vitals. On the other: the way you actually feel when you wake at 3 a.m. with your heart going like a trapped bird. The exhaustion that sleep doesn’t touch. The sense that something essential has gone missing. And no one will name it.

Conventional medicine is exquisitely built for one side of that gap and nearly blind to the other. We are trained to ask what is wrong with your body. We are not trained to ask what is happening to your life.

When the labs come back clean, we say: Everything looks normal.

That sentence does more harm than most diagnoses I have ever written.

Normal is not the same as well

Here is what I wish someone had told me earlier in my career, and what I now tell my patients: a normal result is not a verdict on your suffering. It is the limit of the instrument.

A blood test measures what a blood test can measure. It cannot measure grief. It cannot measure the slow corrosion of a life lived out of alignment. It cannot detect a nervous system that has been in a threat state so long it no longer knows how to return to baseline. The HPA axis doesn’t have an off switch you can order. The biology is real. It simply doesn’t fit on the panel we ordered.

When we treat the absence of an abnormal number as the absence of a problem, we don’t just miss the diagnosis. We tell the patient that their experience is not trustworthy. We hand them a quiet shame on top of their pain.

A different map

In my own practice and in my own healing, I’ve come to use what I think of as a four-dimensional map.

The biochemical layer — the one we already measure — is the first dimension. The second is somatic: what the body is holding in its posture, its pain, its breath. The third is temporal: how a life is patterned across days and seasons, across circadian rhythms that modern schedules have quietly dismantled. The fourth is relational and existential: the meaning, the connection, the identity underneath it all.

A clean panel only clears the first dimension. The other three are often where the real story lives.

Your body is not the problem

Your body is not betraying you. Your body is doing exactly what it was built to do — responding, with precision, to a life that has asked too much of it for too long.

The symptom is not the malfunction. The symptom is the message.

The work of healing is not to silence that message faster.

It is to finally, carefully, listen.

For everyone whose labs are normal and whose life is quietly disappearing — you are not imagining it. You are not broken.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com. His work appears in KevinMD, Op-Med, Medium, Elephant Journal, and San Antonio Medicine.